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ABSTRACT

Autism is a complex developmental disorder in which
impairments of social interaction and communication are

present. Currently, there are few effective treatments for

treating deficits in social communication and the
development of new therapies has been impeded by the lack

of animal models. Thus, the purpose of this study was to
determine if Fischer 344

(F344) rats, a strain which

naturally shows deficits in social communication during
adolescence,

could be used as a model of the social

communication deficits observed in autism. Specifically,

we measured ultrasonic vocalizations (an early onset form

of social interaction) to determine if preweanling F344
rats would show deficits in social communication when
compared to Sprague Dawley rats

(SD). We also investigated

the role of monoamines in the social communication of F344
and SD rats by using selective monoaminergic compounds

(i.e., atomoxetine, GBR-12909, and fluoxetine)

to modulate

monoamine activity. Monoamine activity in the striatum was

also measured. On postnatal day (PD)

15,

rats were

injected 30 minutes prior to testing with 0.3,

mg/kg atomoxetine,

1, or 3

1.5, 5, or 15 mg/kg GBR-12909, or 3,

10, or 30 mg/kg fluoxetine, or vehicle. Ultrasonic
vocalizations were then measured for 20 minutes followed

iii

by an immediate measurement of rectal temperature.
Overall,

F344 rats emitted more ultrasonic vocalizations

regardless of drug treatment. Atomoxetine

(1 and 3 mg/kg)

increased the frequency of ultrasonic vocalizations were

compared to vehicle-treated rats. GBR-12909-induced

ultrasonic vocalizations were altered by both strain and
sex. In male rats, 1.5 mg/kg GBR-12909 increased

ultrasonic vocalizations in F344 rats, but not in SD rats.

In contrast, female rats exhibited a brief increase in
vocalizations after the 5 mg/kg dose. Rats treated with

fluoxetine (30 mg/kg) emitted fewer ultrasonic
vocalizations than rats treated with the lowest dose of

fluoxetine (3 mg/kg) or vehicle. The results indicated
that the social communication of preweanling F344 rats and

SD rats differed. Specifically, F344 rats emitted more
ultrasonic vocalizations than did SD rats. This difference
was not altered by changes in monoamine activity, because
F344 rats and SD rats typically responded in a similar

manner to the selective monoamine compounds. This finding
was surprising because basal levels of dopamine and

serotonin turnover are lower and norepinephrine levels are
higher in F344 than SD rats. Overall,

these data suggest

that F344 rats maybe useful for assessing early onset

iv

social communication deficits and the role of monoamines
in these behaviors warrants further investigation.
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CHAPTER ONE

INTRODUCTION

Delays in the development of social interaction and
communication have been linked to a wide range of

disorders, including anxiety, mood, and substance use

disorders (Gillis, Callahan,

& Romanczyk,

Merikangas, Nakamure, & Kessler,

2011;

2009). These delays are

particularly important for the diagnosis of pervasive

developmental disorders (PDDs), such as autism, Asperger's

disorder, Rett's disorder, and childhood disintegrative
disorder (American Psychiatric Association, 2000; Levy,
Mandell,

& Schultz,

2009). In particular, the presence of

social interaction deficits is considered to be the

definitive diagnostic criteria for autism and
distinguishes autism from other developmental psychiatric
conditions

(Constantino & Todd, 2003).

Autism
Overview

Autism is a complex neurodevelopmental disorder in

which impairments of social interaction and communication

are present and accompanied by restricted and repetitive

behaviors

(Corbett, Schupp, Levine,

Landa, Holman,

& Mendoza,

2009;

& Garrett-Mayer, 2007). Symptoms gradually
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begin after the age of six months and continue into

adulthood (Rogers, 2009) . Currently, no definitive

biological markers exist for autism and diagnosis relies

on the recognition of behavioral symptoms which can vary
greatly from case to case (Liu, King,

& Bearman,

2010).

Diagnosis of Autism
The Diagnostic and Statistical Manual of Mental
Disorders, 4th ed. , text revision (DSM-IV-TR)

defines

autism by the presence of two symptoms of social
interaction impairments, at least one symptom of
communication impairment, and at least one symptom of

restricted and repetitive behavior (American Psychiatric

Association, 2000) . Repetitive patterns of behavior are

defined as repetitive movements (stereotypy) , arrangement
of objects

(compulsive behavior), resistance to change

(sameness), unvarying routine for daily tasks

behavior),

limited focus,

(ritualistic

interest, or activity

(restricted behavior), and self injury or injury to others

(self-injury)
Folstein,

(Dominick, Davis, Tager-Flusberg,

2007; Johnson, Myers,

&

& Council on Children with

Disabilities, 2007; Lam & Aman, 2007). No one pattern of

repetitive behavior is specific to autism and symptoms
vary widely (Bodfish, Symons, Parker, & Lewis, 2000) .
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The onset of symptoms in autism must be prior to the
age of three (American Psychiatric Association,

2000) .

Diagnostic instruments commonly used are the Autism

Diagnostic Interview-Revised (ADI-R)

(parent interview)

and the Autism Diagnostic Observation Schedule

(ADOS),

where children are observed during interaction with other

children. The Childhood Autism Rating Scale

(CARS)

is

widely used to assess the severity of autism (Volkmar,
Chawarska, & Klin, 20 05) .
Socialization and Communication in Autism

The social deficits in autism distinguish this
disorder from other developmental disorders

(Rapin &

Tuchman, 2008) . Children with autism display impaired

non-verbal behaviors such as eye contact and imitation
(Levy, et al., 2009; Sigman, Dijamco, Gratier,
2004; Volkmar et al.,

& Rozga,

2005). Children with autism also

display an absence of seeking shared enjoyment and
interests with other children (Levy et al., 2009) . The
absence of these behaviors results in delayed development

of peer interactions,

few or no friendships, and little

interaction with other children (Levy et al., 2009) .
Autistic children tend to form attachment relationships

with their primary caregiver, but display less attachment

security than non-affected children (Sigman et al., 2004) .
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Communication deficits are also apparent by the first

year and include delays in babbling, gestures, and lack of
response to other children and peers

Berckelaer-Onnes, Verpoorten,

(Noens, van

& van Duijn,

2006) . Autistic

children by the age of two or three express fewer words

and word combinations, and are more likely to engage in
repetition of words than non-affected children (Landa,
2007; Tager-Flusberg & Caronna, 2007). A lack of attention

is also evident in autistic children which coincides with
difficulty in imaginative play and development of symbols

for language

(Landa, 2007; Tager-Flusberg & Caronna,

2007).

Neurobiology of Autism

Neuroimaging and neuropathalogical procedures have
been used to study the morphological brain abnormalities
in autism (Pardo & Eberhart, 2007). This type of
investigation has revealed that autistic infants have a

reduced brain size at birth followed by a large increase

in head circumference (Courchesne, 2004; Courchesne,
Redcay,

& Kennedy,

2 0 04) . Abnormal patterns of brain

overgrowth in areas of the frontal lobe, cerebellum, and

limbic structures between two and four years of age have

also been noted (Courchesne,

2004; Courchesne & Pierce,

2005). Importantly many of the brain areas showing
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abnormal growth have also been linked to the development

of social communication and motor abilities

(Dawson,

Munson, Estes, Osterling, McPartland, Toth, Carver, &

Abbott, 2002).
In addition to neuroanatomical structures, many
neurochemicals have been studied in autism. In particular,

the monoamines, serotonin and to a lesser extent dopamine

and norepinephrine, have been the focus of investigation.
Hyperserotonemia

(high platelet levels of serotonin)

is

one of the most replicable findings in biological
psychiatry (Janusonis,

2008) and occurs in one third of

prebupertal children with autism (JanuSonis,

2008) .

Interestingly, research on the serotonin transporter gene

(SLC6A4), which encodes for both the platelet and neuronal

transport of serotonin, has been linked to a deficiency in

serotonin activity in autistic children (Lam, Aman, &
Arnold,

2006) . Specifically,

it is believed that the

serotonin transporter in some autism patients is

overactive and leads to a decrease in synaptic serotonin
activity (Lam et al.,

2006). While most research has

focused on serotonin, dopamine and norepinephrine have
also been implicated in autism. For example,

CSF levels of

the dopamine metabolite, homovanillic acid (HVA),

is

elevated in autistic children, who exhibit high levels of
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locomotor activity and severe stereotypies
Svennerholm,

(Gillberg &

1987; Narayan, Srinath, Anderson, & Meundi,

1992). In addition, elevated plasma norepinephrine levels
have been found in autistic children (Lam et al., 2006).
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CHAPTER TWO
MONOAMINES: OVERVIEW

Serotonin
Serotonin is an indolamine neurotransmitter involved
in the regulation of mood, eating, body temperature,

arousal, pain sensitivity,
release

sexual behavior, and hormone

(Bauman & Kemper, 1994). Additionally, serotonin

dysfunction is involved in many psychiatric disorders,

including depression, anxiety, obsessive-compulsive
behaviors, and autism (Best, Nijhout,

& Reed,

2010; Dayan

& Huys, 2008) . Cell bodies of serotonergic neurons are
found in nine clusters, most of which are located in the
raphe nucleus in the pons and medulla, which send
projections to the cerebral cortex (Carlson,

2001).

The synthesis of serotonin begins with the

hydroxylation of tryptophan by tryptophan hydroxylase
(TPH)

to create 5-hydroxytryptophan (5-HTP)

(Lam et al.,

2006). This reaction is the rate-limiting step in the
formation of serotonin (Lam et al., 2006; Neckameyer,

Coleman, Eadie, & Goodwin, 2007). After tryptophan is
converted into 5-HTP,

it is decarboxylated by 5-HTP

decarboxylase into serotonin (Lam et al., 2006). Once
serotonin is formed, it is moved into vesicles by the
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vesicular monoamine transporter (VMAT)

(Elsworth & Roth,

1997). When an action potential is generated on a
serotonin neuron, voltage-gated calcium channels

(VGCC) on

the terminal button are activated, which allows an influx
of calcium into the cytosol. The influx of calcium

triggers the process of exocytosis, which causes vesicles

filled with serotonin to fuse with the membrane and allows
serotonin to be released into the synaptic cleft

(Best et

al., 2010; Elsworth & Roth, 1997).

In the synaptic cleft, free floating serotonin is

pumped back into the cytosol of the presynaptic neuron
where it is catabolized (Best et al., 2010). The removal
of serotonin from the synaptic cleft is accompanied by

serotonin reuptake transporters

(SERT)

(Best et al.,

2010). Serotonin then undergoes metabolism through the
process of oxidation in the presence of monoamine oxidase

(MAO)

(Best et al., 2010). The action of MAO converts

serotonin to 5-hydroxyindole acetaldehyde which,

in turn,

is readily metabolized by an isoform of aldehyde
dehydrogenase

(ALDH2)

located in mitochondria. The product

of this metabolic is 5-hydroxyindole acetic acid (5-HIAA),
which is the major metabolite of serotonin (Best et al.,

2010) .
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Serotonin Receptors

Serotonin receptors consist of seven families
(SHTx-v) , and are classified according to their structure,

pharmacology, and signal transduction characteristics

(Murrin, Sanders,

& Bylund, 2007). Some of the serotonin

receptor families contain multiple subtypes
id/

ie/

if/

2A/ 2b/ 2C/

ba/

sb)

(i.e., iA, iB,

(Murrin et al., 2007) . The 5HT3

receptor is a ligand-gated ion channel, whereas the other
receptors

(i.e., 5HTi, 5HT2/ 5HT4, 5HT5, 5HT6,

5HT7) are G

protein-coupled receptors (Hoyer, Hannon, Martin, 2002;

Murrin et al., 2007). The 5HTi receptor is coupled to Gi

proteins; 5HT4, 5HT6, and 5HT7 receptors are coupled to Gs
proteins; and 5HT2A, 5HT2B, and 5HT2C receptors are coupled
to Gq/n proteins

(Hoyer, Clarke, Fozard, Hartig,

Mylecharane, Saxena,

& Humphrey, 1994).

Dopamine
Dopamine is a catecholamine involved in a wide range

of behaviors and functions, including cognition, motor

movement, reward mechanisms,

sexual behavior,

neuroendrocrine regulation, and selective attention

(Caine, Chase, & Barbeau,

1975; Missale, Nash, Robinson,

Jaber, & Caron, 1998; Roberts, Woodruff,

& Iversen,

1978).

Dopamine has been linked to neurological and psychiatric
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disorders, such as schizophrenia, attention-deficit/

hyperactivity disorder (ADHD), and Parkinson's disease
(Bortolato, Chen, & Shih, 2008; Giedd, Keshavan,

& Paus,

2009). Dopamine neurons are primary located in the

substantia nigra and the ventral tegmental area (Carlson,

2001). Cell bodies located in the substantia nigra project
their axons to the neostriatum. Cell bodies in the ventral

tegmental area project to several parts of the prefrontal

cortex and limbic system,

including the nucleus accumbens,

amygdala, and hippocampus (Devoto & Flore, 2006; Wanat,
Willuhn, Clark, & Phillips,

2009).

Dopamine is synthesized from the amino acid tyrosine
(Carlson, 2001; Elsworth & Roth,

1997). Tyrosine is

hydroxylated by tyrosine hydroxylase into
L-dihydroxyphenylaline (L-DOPA)

(Elsworth & Roth,

1997).

This is the rate-limiting step in the synthesis of

dopamine (Carlson, 2 0 01; Elsworth & Roth,

1997) . L-DOPA is

then converted into dopamine via the enzyme DOPA

decarboxylase (Elsworth & Roth, 1997). Once dopamine is
formed it is moved into vesicles by VMAT (Elsworth & Roth,

1997). When the presynaptic terminal is depolarized, an
influx of calcium causes the vesicles to fuse with the
membrane and allows dopamine to be released into the
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synaptic cleft via calcium-dependent exocytosis

& Roth,

1997; Ford, Gantz, Phillips,

(Elsworth

& Williams,

2010).

Free floating dopamine in the synaptic cleft is
inactivated by reuptake, in which dopamine is pumped back
in the presynaptic terminal via dopamine transporters

(DAT)

(Elsworth & Roth,

1997; Ford et al., 2010). Once

transported back into the presynaptic terminal by DAT,
dopamine is metabolized by MAO (Elsworth & Roth,

1997).

Intracellular MAO metabolizes dopamine into
3,4-dihydroxyphenylacetaldehyde

(DHPA). Via oxidization,

DHPA is turned into 3,4-dihydroxyphenyl acetic acid

(DOPAC) by aldehyde dehydrogenase. The end product, HVA,
is found in humans, whereas DOPAC is the major metabolite

found in rodents

(Elsworth & Roth, 1997; Ford et al.,

2010). Dopamine remaining in the extracellular fluid is
metabolized into 3-methoxytyramine (3-MT) by the enzyme
cetechol-o-methyltransferase (COMT). MAO then converts 3-

methoxytyramine (3-MT)

into 3-methoxy- 4-

hydroxyphenylacetaldehyde

(MHPA),

followed by the

conversion of MHPA into HVA by aldehyde dehydrogenase
(Elsworth & Roth, 1997; Ford et al., 2010).
Dopamine Receptors
There are two families of dopamine receptor, DI-like

and D2-like, which are categorized into five different
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subtypes

(Dx-D5)

(Civelli, Bunzow,

Gingrich & Caron,

1994; O'Dowd,

& Grandy,

1993;

1993; Jackson & Westlind-Danielsson,

1993). The two families differ

pharmacologically,

structurally, and biochemically. In the

Dl-like family are the Dx and D5 receptors, while the
D2-like family includes the D2, D3j and D4 receptors. Both

families belong to a class of seven transmembrane G
protein-coupled receptors (Missale et al., 1998; Sealfon &

Olanow, 2000) . Dopamine receptors are coupled to various

G-proteins

(Gs, Goif, Gi)

(Binder, Kinkead, Owens,

&

Nemeroff, 2001) . Di-like receptors are coupled to Goif/Gs
proteins, which stimulate adenylyl cyclase and promote the
production of cyclic AMP (cAMP); whereas, the D2-like

receptors are coupled to the G± protein, which inhibits
adenylyl cyclase (Missale et al., 1998).

Norepinephrine
Norepinephrine is a catecholamine neurotransmitter

involved in functions such as arousal, mood,
learning, and stress response (Page, Oropeza,
Bockstaele,

attention,
& Van

2008). Norepinephrine has been linked to many

neuropsychiatric disorders, including mood and anxiety

disorders, posttraumatic stress disorder, ADHD, and
Alzheimer's disease (Ressler & Nemeroff,
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1999).

Norepinephrine cell bodies are localized in the lateral

tegmental area and the brainstem (i.e., locus ceruleus

(LC)

(Dent, Smith, & Levine,

Sofuoglu & Sewell,

2001; Page et al., 2008;

2008; Tully & Bolshakov, 2010). Like

dopamine, norepinephrine functions as a hormone in the

blood stream or as a neurotransmitter in the brain (Tully

& Bolshakov, 2010).
Norepinephrine shares the same biosynthetic pathway

as dopamine; however, norepinephrine-specific neurons
contain dopamine-p-hydroxylase within their vesicles,

which rapidly transforms dopamine to norepinephrine via
hydroxylation. When the cell is activated,

the vesicles

fuse with the presynaptic membrane allowing norepinephrine
to be released into the synaptic cleft via

calcium-dependent exocytosis (Elsworth & Roth,

1997; Ford

et al., 2010).
The presence of norepinephrine in the synaptic cleft

triggers the prompt inactivation of norepinephrine through
active reuptake. The reuptake of norepinephrine into the
presynaptic terminal is controlled by norepinephrine
transporters

(NET)

(Ressler & Nemeroff, 1999; Sofuoglu &

Sewell, 2008) . Metabolism of norepinephrine occurs by
transformation of norepinephrine into

3,4-dihydroxyphenylglycol (DHPG) or 3,4-dihydroxymandelic
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acid (DHMA) by dehydrogenase or reductase enzymes within

the cell

(Ressler & Nemeroff, 1999). COMT transforms DHPG

and DHMA into 3-methoxy-4-hydroxyphenylglycol (MHPG)

3-methoxy-4-hydroxy-mandelic acid (VMA)
Nemeroff,

or

(Ressler &

1999). The breakdown of MHPG is relatively

specific for central nervous system norepinephrine
metabolism and is a useful plasma/urine marker (Ressler &
Nemeroff, 1999; Weiner & Molinoff,

1994)

Norepinephrine Receptors
Adrenergic receptors consist of three subtypes, a-1,

a-2,

and p which differ in pharmacology, molecular

structure, and signal transduction pathways
al.,

2007) . These three receptors can be further divided

into subtypes
p-1,

(Murrin et

p-2,

p-3)

(i.e., al-A, a-lB, a-lD; a-2A, a-2B, a-2C;
(Murrin et al., 2007). All adrenergic

receptors are G protein-coupled, with a-1 receptors

coupled to Gq, a-2 receptors coupled to Gi/O, and p

receptors coupled to Gs (Murrin et al., 2007).
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CHAPTER THREE
ONTOGENY OF MONOAMINES

Serotonin Ontogeny
Prenatal Development

Serotonergic neurons are apparent around embryonic
day 12

(Aitken & Tork, 1988; Murrin et al., 2007) .

Serotonin fiber projections can be detected by embryonic

day 14 and reach the prefrontal neocortical pole by
embryonic day 17

(Murrin et al., 2007). Around embryonic

day 14 descending serotonin fibers enter the spinal cord
and axons innervate preganglionic sympathetic neurons and
somatic motor neurons to form synapses by embryonic day 17
(Rubenstein,

1998).

Postnatal Development

A rapid growth of serotonin dendrites is evident

until the end of the first postnatal week (Murrin et al.,
2007). By postnatal day (PD)

15,

serotonin synaptogenesis

is at approximately 75% of adult levels in the raphe
nucleus

(Murrin et al., 2007). In the basal forebrain,

the

percentage of serotonin varicosities engaged in synaptic
junctions increase from birth to adult levels by the end

of the second postnatal week (Murrin et al., 2007) .
Serotonin levels in the CNS are low at birth and generally

15

peak around PD 21 to 30 and then decline to adult levels
(Murrin et al., 2007).
Serotonin Receptor Development

5HT1 serotonin receptors subtypes
if)

(5-HTia,

ib,

id,

and

are expressed by embryonic day 16 in the thalamus and

hippocampus

(Murrin et al., 2007) . 5HT2 receptors can be

detected by approximately embryonic day 17 throughout the

whole brain (Murrin et al., 2007) .
At birth, 5HTi receptor binding in the brainstem is

higher than adult levels and appears to be fully
functional

(Murrin et al., 2007). In the striatum [3H]5-HT

binding is only 12% of adult levels at birth, however,
increases rapidly by the third week of age

(Murrin et al.,

2007). Immunocytochemical techniques reveal that 5-HT2C,
5-HT5a,

and 5-HT7 receptors in four regions of the rat

hippocampus are at their highest levels at birth and then
decrease to adult levels (Murrin et al., 2007) .

Dopamine Ontogeny

Prenatal Development
Dopamine neurons in the striatum appear between

embryonic day 10 and embryonic day 14,
Altschuler,

(Maciag,

Slack, Krogan, Emili, Greenblatt, Maniatis &

Wu, 2006). On embryonic day 13, dopamine axons from the
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substantia nigra and the ventral tegmental area start to
extend dorsally to the ventral striatum, but are not fully
mature until birth (embryonic day 21)
Crockett,

(Hu, Cooper,

& Zhou, 2004) . By embryonic day 14 extensive

development of dopamine activity is evident in the

striatum (Specht, Pickel, John,

& Reis, 1981; Maciag et

al., 2006). HLPC studies measuring catecholamines and

their metabolites show a 9 fold increase in dopamine

concentrations in the midbrain from embryonic day 17 to

PD 0

(Pares-Herbute, Tapia-Arancibia, & Astier,

1989).

Postnatal Development
At PD 7, dopamine synapses in the dorsal striatum
peak and then gradually decline to adult levels around

PD 21 (Antonopoulos, Dori, Dinopoulos, Chiotelli,
Parnavelas,

2 0 02) . Dopamine distribution in the prefrontal

cortex develops slower than in the striatum (Kalsbeek,
Voorn, Buijs, Pool,

& Uylings,

1988).

Dopamine Receptor Development
By embryonic day 14, Dl-like and D2-like receptor
mRNA is detectable in the caudate-putamen, olfactory

tubercle,

frontal cortex, and cingulate cortex (Schambra,

Duncan, Breese, Fornaretto, Caron,

& Fremeau,

1994) .

Dl-like receptor mRNA levels at birth are 75% of adults,
however, D-like receptor binding is very low (Schambra et

17

al., 1994). The density of DI-like binding sites increases

between PD 14 to 21, where it remains relatively stable

throughout adulthood (Schambra et al., 1994). Dl-like
receptors reach adult levels faster and have greater

densities than D2-like receptors

(Broaddus & Bennett,

1989; Schambra et al., 1994). Some studies, however,

show

that D2-like receptors are expressed by PD 3 and reach
adult levels by PD 21

(Rao, Molinoff,

Sales, Martes, Bouthenet, & Schwartz,

& Joyce,

1991;

1989).

Norepinephrine Ontogeny
Prenatal Development

Noradrenergic neurons appear between embryonic day 10

and 13

(Murrin et al., 2007). From this point there is a

linear development of markers for noradrenergic neurons in

the central nervous system, approximately increasing 100-

to 1000-fold by adulthood (Murrin et al., 2007) . Axial
projections reach their terminal areas a week before birth
and start to form varicosities (Murrin et al., 2007).
Postnatal Development

The development of norepinephrine concentrations to
adult levels in rat brain is relatively slow compared to
other monoamines (Murrin et al., 2007). Norepinephrine

levels increase steadily from birth onward, however, adult
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concentrations are not reached until PD 30 to 40

(Murrin

et al., 2007) .
Adrenergic Receptor Development

a-1 Adrenergic receptors are found in low levels in

rat brain at birth (Murrin et al., 2007).

Density of ot-l

adrenergic receptors increases rapidly between PD 15 and
20

(Murrin et al., 2007). By PD 20,

levels of a-1

adrenergic receptors are greater than in adults,

followed

by a decrease to adult levels in the following weeks
(Murrin et al.,

2007). a-2 Adrenergic receptors

(i.e.,

a-2A, a-2B, and a-2C), exhibit a distinct transcriptional
developmental profile throughout the central nervous

system (Murrin et al., 2007). An increase in a-2
adrenergic receptors density occurs in most brain regions
after birth and reaches peak levels at about PD 15

(Murrin

et al., 2007). [3-Adrenergic receptors in the rat brain
exist in very low levels shortly after birth (Murrin et
al.,

2007). By the second week of postnatal development,

however,

adults

|3-adrenergic receptors levels are greater than in

(Murrin et al., 2007).
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CHAPTER FOUR

RODENT SOCIAL COMMUNICATION THROUGH PLAY
BEHAVIOR AND VOCALIZATION

The development of social communication and
interactions in children is evident early in life and

increases in complexity as a child matures
Holcombe,

(Brown, Odom, &

1996). It has been proposed that appropriate and

effective social behavior acquisition with peers is

important for early social development

(Brown et al.,

1996). The formation of strong social bonds is also
important for the well being of individuals and is a

critical criterion for mental health (Young, Liu, & Wang,
2004). Thus, the inability to form social bonds has been

used as a diagnostic component of various psychological
disorders, including autism,

social anxiety, and

schizophrenia (Young et al.,

2004) .

Social Communication through Play Behavior
In rodents, social play is one of the earliest forms

of non-mother-directed social behavior

Niesink, & Van Ree,

1997; Young et al.,

(Vanderschuren,

2004). Play

behavior is also necessary for normal social development
in rodents and is a common model used to assess
impairments in social interactions
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(Vanderschuren et al.,

1997). Social play in young rats consists of various
behavioral patterns, including pouncing, chasing,

social

grooming, crawling over/under, charging, boxing,
wrestling, pinning, social sniffing, and lateral display
(Baenninger,

1967; Bolles & Woods, 1964; Meany & Stewart,

1981; Panksepp & Beatty,

1980; Poole & Fish, 1975). Social

development (i.e., social, sexual, and aggressive

behaviors)

in rodents is facilitated by social play

(Vandershuren et al., 1997). Moreover, play deprivation
causes abnormal patterns of social behaviors

(Vandershuren

et al., 1997). Within a litter, rats show preferences for

specific play partners and rats that play less have weaker
ties with the group in later life (Bekoff, 1974; Carlsen &

Heimer, 1986). Social play in infant rats is also
important for learning to express and understand
intraspecies communicative signals, which may serve to

inhibit aggression and increase group stability (Bekoff,

1972; Lore & Planelly,

1977; Meany & Stewart,

Stewart, & Beatty 1985). Thus,

1981; Meany,

social play behavior

facilitates different aspects of social development, which

may contribute to the acquisition of adequate social

functioning (Vandershuren et al.,

1997).

An important disadvantage to using play behavior as a
model of social communication,
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is that play behavior is

typically assessed in rats after weaning and peaks after

PD 30

(Auger & Olesen, 2009; Siviy & Panksepp,

2011). This

play behavior model corresponds to late childhood to early

adolescence in humans, and therefore, cannot be used as a
model of early onset social communication disorders like

autism.

Social Communication through Vocalization
Ultrasonic vocalization is another form of social

communication in rodents. Unlike social play, however,

ultrasonic vocalizations are evident just hours after

birth (Dastur, McGregor, & Brown,

1999; Hofer,

1996) . The

emission of ultrasonic vocalizations also plays an
important role in parent-infant interactions
Tai, Broders, An, Zhang, He, An,

& Wu,

(Yu, Wang,

2011).

Ultrasonic vocalizations in infant rats have been

studied under a variety of conditions; however, one of the
most effective methods for inducing vocalization is

through isolation stress

(Shair, Masmela,

& Hofer, 1999).

Emission of ultrasonic vocalizations in young rodents is a
distress response produced when under cold stress or when

separated from their dam and littermates

(Allin & Banks,

1970; Hofer & Shair, 1978; but see Blumberg, Sokoloff,
Kent,

1999). Importantly, isolation-induced ultrasonic
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&

vocalizations have been interpreted as a communicative

behavior, which can be used to model several
neuropsychiatric and neurodevelopmental disorders
associated with communicative/social deficits

(Scattoni,

Crawley, & Ricceri, 2009).

Neurobiology of Ultrasonic Vocalization
and Social Play
Multiple neurochemical systems modulate ultrasonic
vocalization emission,

including serotonin,

norepinephrine, and dopamine

(Dastur et al., 1999).

Serotonin's effect on ultrasonic vocalization emission
varies and depends on which receptor subtype is activated

(Dastur et al., 1999). For example,

in 10-day-old rats

serotonin 5HTiA receptor agonists reduce ultrasonic
vocalizations
Whitten,

(Kehne, McCloskey, Baron, Chi, Harrison,

& Oalfreyman,

1991; Winslow & Insel,

1990), while

5HTib receptor agonists increase ultrasonic vocalizations

(Winslow & Insel,

1991). Antagonists at 5HT2A receptors

and serotonin reuptake inhibitors suppress ultrasonic
vocalizations (Winslow & Insel,

1990). Norepinephrine also

modulates ultrasonic vocalizations, because the

p-adrenoceptor antagonist, propranolol, the
a-2-adrenoceptor antagonist, yohimbine, and the

ot-l-adrenoceptor antagonist, prazosin, all decreases
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ultrasonic vocalizations in 8- to 12-day-old. rat pups,

while the ce-2-adrenoceptor agonist,

clonidine,

increases

ultrasonic vocalizations in 4- to 16-day-old rat pups
(Kehoe,

1988; Winslow & Insel, 1991). Lastly,

studies

looking at dopamine modulation of ultrasonic vocalizations

have shown that dopamine DI and D2 receptors may modulate

ultrasonic vocalizations emission differently (Dastur et
al., 1999). In 10-day-old rat pups,

the DI receptor

agonist SKF 81297 suppressed ultrasonic vocalizations,
whereas the selective D2 receptor antagonist sulpiride

decreased ultrasonic vocalizations in 12- to 14-day-old
rat pups

(Cuomo, Cagiano, Renna, DeSalvia,

& Racagni,

1987; Dastur et al., 1999).
Like ultrasonic vocalizations, play behavior in rats

is modulated by monoamine activity. For example, social
play is reduced when blockers of dopaminergic

transmission, such as chlorpromazine and haloperidol, are

administered. Moreover, the serotonin agonist, quipazine,
and the partial agonist, methysergide, both reduce social
play (Beatty, Costello, & Berry,

Panksepp,

1984; Normansell &

1985). In addition, blockade of presynaptic

a-2-adrenoreceptors decreases social play, presumably by

increasing noradrenergic activity (Siviy, Fleischhauer,
Kuhlman, & Atrens, & 1994).
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CHAPTER FIVE
THESIS STATEMENT AND HYPOTHESES

Impairments in social interactions are one of the
earliest signs of developmental delay in children and are

an important diagnostic criteria in many pediatric mental
disorders. Autism,

in particular, can be distinguished

from other developmental disorders by the presence of
social communication deficits. Unfortunately,

these

deficits in social communication are difficult to assess

in animal models and have hampered progress in

understanding the neurobiological bases of disorders, like
autism, and in the development of effective treatments.

Play behavior in young rats is an established model
used to study complex social interactions

(Vanderschuren

et al., 1997). Supporting this idea is research showing

that:

(a) play behavior is disrupted in a number of

development disorders, including autism, Asperger's
syndrome, and attention deficit hyperactivity disorder
(Buitelaar, Swinkels, De Vries, van derGaag,

& Van Hooff,

1994; Buitelaar, Van England, de Kogel, De Vries, & Van

Hooff,

1991; Kirkpatrick, 1994); and (b) play behavior is

necessary for normal social development

Meany et al., 1985; Meany & Stewart,
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(Bekoff,

1972;

1981; Vanderschuren,

Niesink, Spruijt,

& Van Ree, 1995). A major advantage to

the rat play behavior model is that there are known

differences in playfulness between rat strains that can be
used to find genetic and neurobiological substrates for

this behavior. For example, F344 are less playful when
compared to other strains of rats,

including SD rats from

which they were initially derived. F344 rats are less

likely to solicit play and are less likely to respond
playfully when approached or contacted by another rat
(Siviy, Love, DeCicco, Giordano,

& Seifert,

2003).

Consistent with decreased play behavior, F344 rats show
differences in monoamine transmission when compared to SD
rats (Varty & Geyer,

1998).

A disadvantage to the play behavior model, however,

is that play behavior is usually assessed in rats after
weaning and peaks after PD 30

(e.g., a period

corresponding to late childhood to early adolescence in

humans). Thus, this model cannot be used to assess

deficits in social interaction in ages analogous to human

children. The purpose of the present thesis, therefore,
was to determine if F344 rats showed decreased emission of

social communication at a developmental period analogous
to early childhood (e.g., 2-3 years). For this reason,
separation-induced ultrasonic vocalizations were measured
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in F344 and SD preweanling rats on PD 15. In addition, the

ability of specific monoaminergic compounds to modulate
ultrasonic vocalizations was assessed in both rat strains.

These data were then analyzed to determine whether there
was an involvement of serotonin, dopamine, and
norepinephrine systems in separation-induced ultrasonic

vocalizations. Additionally, striatal serotonin, dopamine,

and norepinephrine levels, as well as their major

metabolites, were measured in vehicle-treated rats on

PD 17. Monoamines were assessed in the striatum because
the striatum is important for the mediation of social

behavior (Siviy & Panksepp,

2011; Kirsten et al., 2012)

and abnormalities in this brain area are frequently seen

in autistic individuals
et al.,

(Di Martino et al. 2011; De monte

2012) .

Based on past social play and ultrasonic vocalization
studies, as well as investigations using F344 and SD rats,

a number of hypotheses were made concerning the current
thesis. First, we predicted that vehicle-treated F344 rats

would emit fewer isolation-induced ultrasonic
vocalizations than SD rats, because F344 have a natural

tendency to engage in less social play (Siviy, Love,

DeCicco, Giordano, & Seifert, 2003). We also predicted
that administration of GBR-12909
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[a dopamine reuptake

inhibitor (DRI)] would result in less ultrasonic

vocalization production for both SD and F344 rats, our
rational was that dopamine agonists decrease ultrasonic

vocalizations, while dopamine antagonists decrease social
play (Knutson, Burgdorf, & Panksepp,

1998; Nelson &

Panksepp, 1998) . We predicted, however, that GBR-12909
would have a smaller effect on F344 rats, as compared to
SD rats, because F344 rats appear to be less sensitive to
activation of the dopamine system (Siviy, Crawford,

Akopian,

& Walsh, 2011).

In contrast to the predicted effects of GBR-12909, we

hypothesized that administering atomoxetine

[a selective

norepinephrine reuptake inhibitor (NRI)] would increase

ultrasonic vocalization-emissions in both strains, because
norepinephrine agonists increase ultrasonic vocalizations

and decrease social play (Siviy et al., 1994; Winslow &

Insel,

1991). We also hypothesized that atomoxetine

administration would have an enhanced effect in F344 rats,

as compared to SD rats, because norepinephrine agonists,
in general, produce greater behavioral effects in F344

rats

(Skolnick & Daly, 1977).

Interestingly, serotonin transmission has mixed
effects on social communication. For example, serotonin
reuptake inhibitors decrease ultrasonic vocalization
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production, while serotonin agonists decrease social play
(Beatty et al.,

1984; Normansell & Panksepp,

1985). Based

on prior studies using serotonin reuptake inhibitors, we
predicted that fluoxetine [a serotonin reuptake inhibitor
(SRI)] would decrease ultrasonic vocalization emission in
all rats

(Winslow & Insel, 1990). Additionally, we

predicted that fluoxetine would have a smaller effect on
F344 rats, as compared to SD rats, because F344 rats

appear to be less sensitive to activation of the serotonin
system (Uphouse, Maswood, Jackson, Brown, Prullage, Myers,

& Shaheen, 2002) .
Finally, we predicted that monoamine turnover
(defined as metabolite level/neurotransmitter level)

would

be differentially affected by strain. Specifically, we

hypothesized that dopamine and serotonin turnover would be
lower in F344 rats, when compared to SD rats, while
norepinephrine turnover would be greater in F344 rats.
These monoamine turnover predictions were based primarily

on agonist sensitivity studies

(Beatty et al., 1984;

Nelson & Panksepp, 1998; Normansell & Panksepp,

1985;

Winslow & Insel, 1991) and turnover studies in adult and
adolescent rats

(Uphouse et al., 2002; Varty & Geyer,

1998) .
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CHAPTER SIX

METHODS

Subjects

Subjects consisted of 142 F344 rat pups

75 female)

and 145 SD rat pups

(67 male and

(77 male and 68 female).

Untimed pregnant rats were purchased from Charles River
Laboratories

(Wilmington, MA)

and their pups, after

receiving different drug treatments, were tested on PD 15.

Table 1 summarizes the number of male and female pups from
each strain (F344 or SD) tested under each treatment

condition.
The colony room was maintained at 22-24°C and kept
under a 12-hr light/dark cycle, with behavioral testing
occurring during the light phase of the cycle. Food and

water were freely available. Subjects were treated
according to the "Guide for the Care and Use of Mammals in
Neuroscience and Behavioral Research"

(National Research

Council, 2010) under a research protocol approved by the

Institutional Animal Care and Use Committee of CSUSB.
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Table 1. Subject Assignment

Treatment Conditions

F344
Male
Female
Pups
Pups

Vehicle-treated
(saline or 50% DMSO)
1.5
Rat pups treated
mg/kg
with dopamine
5 mg/kg
reuptake inhibitor
15
(DRI: GBR-12909)
mg/kg
Rat pups treated
0.3
with selective
mg/kg
norep inephrine
1 mg/kg
reuptake inhibitor
3 mg/kg
(NRI: Atomoxetine)
3 mg/kg
Rat pups treated
10
with serotonin
mg/kg
reuptake inhibitor
30
(SRI: Fluoxetine)
mg/kg

SD
Female
Pups

21

24

21

15

4

6

5

7

5

6

7

6

6

5

6

6

5

6

7

5

6

5

6

6

5

6

7

4

4

.6

5

7

5

6

7

6

6

5

6

6

67

Total

Male
Pups

75
N = 142

77

68
N = 145

Design of the Experiments
Three experiments were designed to test the proposed

hypotheses: The first experiment involved the
administration of the dopamine reuptake inhibitor (DRI:

GBR-12909), the second experiment involved the

administration of the selective norepinephrine reuptake

inhibitor (NRI: atomoxetine) , and the third experiment
involved the administration of the serotonin reuptake

inhibitor (SRI: fluoxetine).
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In the first experiment, a 2 x 4 x 4 mixed factorial
design was adopted. The first independent variable "rat

strain" was a between-subjects variable with two levels
(the F344 rats and the SD rats). The second independent
variable "drug condition" is a between-subjects variable

with one vehicle-treated control condition and three
levels

(1.5 mg/kg, 5 mg/kg, and 15 mg/kg) of GBR-12909.

The third independent variable "time block" is a within-

subjects variable with four 5-minute blocks. The dependent
variable is the frequency of ultrasonic vocalizations

produced by each rat during each 5-minute testing block.
The design (not including the "time block" variable)

is

illustrated in Table 2.

Table 2. Experiment 1: GBR-12909 Administration
Rat Strain
SD rats
F344 rats

Vehicle-treated
(saline or 50% DMSO)
Drug
condition 1.5 mg/kg
GBR-12909 5 mg/kg
15 mg/kg

In the second experiment, a 2 x 4 x 4 mixed factorial

design was adopted. The first independent variable "rat
strain" was a between-subjects variable with two levels
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(the F344 rats and the SD rats). The second independent

variable "drug condition" is a between-subjects variable
with one vehicle-treated control condition and three

levels

(0.3 mg/kg, 1 mg/kg, and 3 mg/kg) of atomoxetine.

The third independent variable "time block" is a within-

subjects variable with four 5-minute blocks. The dependent
variable is the frequency of ultrasonic vocalizations

(USVs) produced by each rat during each 5-minute test
block. The design (not including the "time block"

variable)

is illustrated in Table 3.

Table 3. Experiment 2: Atomoxetine Administration
Rat Strain
F344 rats
SD rats

Vehicle-treated
(saline or 50% DMSO)
Drug
condition 0.3 mg/kg
Atomoxetine 1 mg/kg
3 mg/kg

In the third experiment, a 2 x 4 x 4 mixed factorial

design was adopted. The first independent variable "rat
strain" was a between-subjects variable with two levels
(the F344 rats and the SD rats). The second independent

variable "drug condition" is a between-subjects variable

with one vehicle-treated control condition and three

levels (3 mg/kg, 10 mg/kg, and 30 mg/kg) of fluoxetine.
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The third independent variable "time block" is a withinsubjects variable with four 5-minute blocks. The dependent
variable is the frequency of ultrasonic vocalizations

(USVs) produced by each rat during each 5-minute test
block. The design (not including the "time block"

variable)

is illustrated in Table 4.

Table 4. Experiment 3: Fluoxetine Administration
Rat Strain

F344 rats

Drug
condition
Fluoxetine

SD rats

Vehicle-treated
(saline or 50% DMSO)
3 mg/kg
10 mg/kg
30 mg/kg

Note that, in this thesis,

the same vehicle-treated

(saline or 50% DMSO) condition, was used as the control
condition of the "drug condition" variable for all three

experiments.

Drugs

Atomoxetine, GBR-12909, and pentobarbital were mixed
in saline, while fluoxetine was mixed in 50% DMSO. All
drugs were injected intraperitoneally (IP) at a volume of

5 ml/kg. GBR-12909 and pentobarbital were purchased from
Sigma-Aldrich (St. Louis, MO). Atomoxetine and fluoxetine
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were purchased from Toronto Research Chemicals

(Toronto,

Ontario).

Apparatus

The testing apparatus was a Plexiglas testing chamber

(20 x 20 x 20 cm) housed inside a white wooden chamber
(24 x 24 x 22 cm) housed inside a heated terrarium (31°C,
±1°C). A Mini-3 ultrasonic detector (Ultrasound Advice,
London, UK) was suspended above the floor of the testing
apparatus. The ultrasonic detector was tuned to 40 kHz

(±1

kHz), because a setting of 40-45 kHz provides the highest

rate of USV detection (Hofer & Shair,

1978). Ultrasonic

vocalizations were recorded using the Ultravox program and
by observers blind to drug treatment conditions. Body
temperatures were recorded using a BAT-12 microprobe

thermometer (Physitemp Instruments, Piscataway, NJ).
Isolation-Induced Ultrasonic Vocalizations
Procedure
On PD 15, rats were weighed and injected with either

GBR-12909

(DRI; 1.5,

0.3, 1, or 3 mg/kg),

5, or 15 mg/kg), atomoxetine (NRI;
fluoxetine (SRI; 3,

10, or 30 mg/kg),

or vehicle 30 min before testing. Half of the vehicle-

treated subjects were injected with saline and the other

half with 50% DMSO.

(see Tables 2-4.) Thirty minutes after
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injection,

each rat was removed individually from the home

cage, placed in a travel container, and moved to the

testing room. The rat was then placed in the heated
chamber (31°C, ±1°C) where ultrasonic vocalizations were

measured for 20 min. Rectal temperatures were measured
immediately after rats were removed from the test chamber.

Afterwards, the rat were anesthetized with pentobarbital
(20 mg/kg) and returned to the home cage. Rats were
anesthetized to prevent them from emitting ultrasonic

vocalizations while in the home cage. Rat pups were

monitored until fully responsive.
Tissue Monoamine and Metabolite Assay
On PD 17, rats in the vehicle condition from each

strain were decapitated and their striatum rapidly
dissected. Tissue samples were then frozen until day of
assay. On assay day, frozen brain sections were sonicated

in 10 volumes of 0.1 N HC1O4 and centrifuged at 20,000 x g

for 2 0 min at 4°C. The supernatant was then filtered

through a 0.22 p.m centrifugation unit at 2,000 x g for
5 min at 4°C. Twenty microliters of the resulting extracts
were then assayed for dopamine, norepinephrine, and

serotonin using high performance liquid chromatography
(1525 binary pump, 717plus autosampler; Waters, Milford,
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MA, USA, and an MD-150 column; ESA, Chelmsford, MA) with
electrochemical detection (Coulochem II; ESA). The major
monoamine metabolites

(i.e., DOPAC, HVA, 5-HIAA, and MHPG)

were also measured. The mobile phase consisted of 75 mM

NaH2PO4,

1.4 mM 1-octane sulfonic acid,

10 mM EDTA, and

7.5% acetonitrile [(pH 3.0) MD-TM Mobile Phase; ESA]

and

was pumped at a rate of 0.5 ml/min.

Statistical Analysis

Litter effects were controlled by the subject

assignment procedure with no more than one subject per
litter placed in any group. An approximately equal number
of male and female rats were assigned to each group.
Although "sex" of the rat pups was not treated as a major
independent variable in the above-mentioned three

experiments, preliminary data analyses indicated some

interesting and potentially important differences between

male and female pups' differential responses to different
drug treatments. Thus, in some statistical analyses,

the

variable "sex" was included.

In this thesis,

several ANOVAs for mixed designs were

conducted to test the proposed hypotheses. To test the
first hypothesis regarding the difference between the

vehicle-treated F344 rat pups and the SD rat pups in their
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production of separation-induced ultrasonic vocalizations,
a 3-way [2

(rat strain) x 2

(sex)

x 4

(5-minute time

block)] ANOVA was conducted. For each of the three

experiments, to test the hypothesis concerning the effect

of drug treatment on production of ultrasonic
vocalizations,
4-way [2

if the variable "sex" was included, then a

(rat strain) x 2

(sex) x 4

(drug condition)

('5-minute time block)] ANOVA was conducted.

If the

variable "sex" was not included, then a 3-way [2
strain)

x 4

(drug condition) x 4

x 4

(rat

(5-minute time block)]

ANOVA was conducted. The corresponding SPSS program used

was labeled "Repeated measures..." for "General Linear
Model" because, in each experiment, besides the related
between-subjects variables, a within-subjects

repeated-measures) variable (namely,

(or

time block) was

included. For between-subjects variables where three or

more treatment conditions were included, the post hoc test
("Tukey's Honestly Significant Difference (HSD)) was
further performed to identify significant differences

between any two conditions.
For each experiment, data regarding body temperature

were analyzed using a 3-way [2

(rat strain) x 2

(sex) x 4

(drug condition)] ANOVA for a between-subjects design.
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Moreover, to analyze dopamine, norepinephrine,

serotonin,

their metabolites, and turnover rates in the striatum, 2-

way [2

(rat strain)

x 2

(sex)] ANOVAs for between-subjects

designs were conducted. Turnover was defined as

(metabolite/neurotransmitter level). The corresponding
SPSS program used for between-subjects designs was labeled

"Univariate..." for "General Linear Model."
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CHAPTER SEVEN
RESULTS

Ultrasonic Vocalizations in Vehicle-treated Rats

The main effect of rat strain on ultrasonic

vocalization production was significant, F(l, 23)
p < .05. However,

= 6.473,

contrary to our prediction,

vehicle-treated F344 rats (M - 107.93; SEM = ±23.64)

emitted more (rather than fewer) ultrasonic vocalizations
than vehicle-treated SD rats

(M = 40.92; SEM = ±14.76).

The main effect of time block on ultrasonic vocalizations
was not significant; ultrasonic vocalizations did not vary

in frequency over the four five-minute time blocks for
vehicle-treated rats. The main effect of sex and the
interaction effect between rat strain and sex on

ultrasonic vocalizations were also not significant. Both
the F344 female rats and the F344 male rats produced more

ultrasonic vocalizations than their SD counterparts.

Ultrasonic Vocalizations after
GBR-12909 Administration

The results regarding the administration of the
dopamine reuptake inhibitor (GBR-12909)

are illustrated in

Figures 1 and 2. As can be seen from Figure 1,

administration of GBR-12909 [dopamine reuptake inhibitor
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(DRI)]

did not result in less ultrasonic vocalization

production for either the SD or the F344 rats. For the SD
rats, no significant difference in ultrasonic vocalization
production was observed between any two of the three GBR
conditions

(1.5,

5, and 15 mg/kg GBR-12909)

or between any

one of the three GBR-12909 conditions and the vehicletreated condition (0 mg/kg GBR-12909). This result was
consistently observed across all four 5-minute time
blocks. For the F344 rats, ultrasonic vocalization

production was higher for those treated with 1.5 mg/kg

GBR-12909 as compared to those treated with the vehicle or
those treated with either 5 or 15 mg/kg GBR-12909,

especially for the last two time blocks.

[This set of

results was suggested by the significant rat strain x drug
condition x time block interaction effect on the

ultrasonic vocalization production, F(9,216)

= 2.721,

p < .005, and the outcome of the Tukey tests.]

The results

illustrated in Figure 1, also did not suggest that
GBR-12909 had a smaller effect on F344 rats as compared to

SD rats.

Figure 2 illustrates how rat strain, sex, and drug
condition interact to affect ultrasonic vocalization
production. Over the 20 minute testing period, ultrasonic
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vocalization production was higher for F344 rats as
compared to SD rats.

[This is suggested by the significant

"rat strain" main effect, F(l, 72)

= 8.037, p < .05].

Compared to their female counterparts, F344 male rats
appeared to be more sensitive to GBR-12909 administration.
As can be seen from Figure 2, male F344 rats

female F344 rats)

(but not

treated with the 1.5 mg/kg dose produced

more ultrasonic vocalizations than those treated with the

5 or 15 mg/kg doses
from Figure 1,

[Tukey test, p < .05] . As can be seen

for some yet to be determined reason, both

the vehicle-treated F344 rats and SD rats tended to
produce considerably low amounts ,of ultrasonic
vocalizations. Due to the very low levels of baseline

vocalization production, a potential floor effect might
I

have occurred, thus making it difficult for any potential
drug-induced decline in vocalizations to occur.

Body Temperature
The administration of different amounts of GBR-12909

did not differentially affect the body temperatures of

rats from either strain. However, F344 preweanling rats
had lower rectal temperatures

(M = 36.89°C,

than preweanling SD rats (M = 37.45 °C,
[strain main effect, F(l, 80)
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SEM = +0.15)

SEM = +0.79)

= 9.733, p < .05] .

GBR-12909

GBR (mg/kg)

5-Min Time Blocks

Figure 1. Mean Ultrasonic Vocalizations

(USVs)

for F344

Rats and SD Rats on PD 15. Rats were Treated with. Vehicle
or GBR-12909 (1.5, 5, or 15 mg/kg,

IP)

30 Minutes Prior to

Testing. f Indicates a Significant Difference from SD rats
(Main Effect of Strain).

*Indicates Significant Difference

from Rats Treated with GBR-12909
vehicle

(Main Effect of Drug).
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(5 or 15 mg/kg) or

GBR-12909

Figure 2. Mean Ultrasonic Vocalizations

(USVs)

for Male

and Female F344 Rats and SD Rats on PD 15. Rats were
J

Treated with Vehicle or GBR-12909

(1.5, 5, or 15 mg/kg,

IP) 30 Minutes Prior, to Testing. ^Indicates1 a Significant
I

Difference from Male Rats.Treated with 1.5 mg/kg (Sex by
I

'

Drug Interaction).

, ,

Ultrasonic Vocalization after Atomoxetine
Administration
Preliminary analyses revealed that the frequency of

ultrasonic vocalizations did not differ across the four

five minute time blocks, thus subsequent analyses were
performed with the data collapsed over time blocks.

The results regarding the administration of the
norepinephrine reuptake inhibitor (atomoxetine)
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are

illustrated in Figure 3. Consistent with our prediction,
administration of atomoxetine did increase ultrasonic

vocalization emissions in both the SD and the F344 rats.
The amount of ultrasonic vocalizations differed according
to atomoxetine dose; rats treated with the two highest
doses of atomoxetine (1 or 3 mg/kg)

exhibited a

significantly greater amount of vocalizations than the

vehicle-treated rats.

[This is supported by the

significant main effect of drug condition,
F(3,

79)

= 4.937, p < .05, and the outcome of the Tukey

tests]. Also consistent with our prediction,
administration of atomoxetine did appear to have an

enhanced effect in F344 rats as compared to SD rats. As

can be seen from Figure 3, the difference in ultrasonic
vocalization production between those rats treated with
the two highest doses of atomoxetine (1 or 3 mg/kg)

and

those treated with vehicle was larger for the F344 rats

than for the SD rats. However, F344 rats had more

vocalizations than SD rats regardless of drug dose.

strain main effect is significant, F(l, 79)

[The

= 25.250,

p < .05]. The effect of atomoxetine administration on

ultrasonic vocalization production did not differ
according to sex.
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Body Temperature
The administration of different amounts of
atomoxetine did not differentially affect the rectal
temperature of rats in either rat strain. However,

preweanling F344 rats

(M = 36.94°C, SEM = ±0.14) did have

a lower rectal temperature than preweanling SD rats
(M = 37.29°C, SEM = +0.13)

F (1,

79)

[strain main effect,

- 10.186, p < .05].
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Atomoxetine

Figure 3. Mean Ultrasonic Vocalizations

(USVs)

for F344

Rats and SD Rats on PD 15. Rats were Treated with Vehicle
or Atomoxetine

(0.3,

1, or 3 mg/kg,

IP)

30 Minutes Prior

to Testing, indicates a Significant Difference from SD

Rats (Main Effect of Strain). *Indicates a Significant
Difference from Vehicle-Treated Rats (Main Effect of

Drug).
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Ultrasonic Vocalizations after Fluoxetine
Administration
Similar to the effects of atomoxetine, vocalizations
after fluoxetine administration did not significantly

differ across the four time blocks. Therefore, data were
collapsed over the time blocks in the analyses for this
experiment.

The results regarding the administration of the

serotonin reuptake inhibitor (fluoxetine) are illustrated
in Figure 4. As can be seen from Figure 4, ultrasonic
vocalizations were dose-dependently affected by

fluoxetine. Partially consistent with our hypothesis,
I

although both the F344 and the SD rats treated with a low

or medium amount of fluoxetine (3 or 10 mg/kg)

did not

produced fewer ultrasonic vocalizations as compared to the

vehicle-treated rats, both the F344 and the SD rats
treated with a high amount of fluoxetine (30 mg/kg)

did

produced fewer ultrasonic vocalizations as compared to the

vehicle-treated rats.

[This is supported by the

significant main effect of drug condition,
F(3,

80)

= 2.878, p < .05; and the outcome of the Tukey

tests]. However, inconsistent with our prediction,

fluoxetine did not seem to have a smaller effect on F344
rats as compared to SD rats.

In general,
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F344 rats emitted

more vocalizations than SD rats regardless of drug dose.

[The strain main effect is significant, F(l,

80)

= 4.424,

p < .05]. Ultrasonic vocalizations after fluoxetine
administration did not differ in accordance with sex. As

can be seen from Figure 1, for some yet to be determined

reason, both the vehicle-treated F344 rats and SD rats
tended to produce considerably low amounts of ultrasonic
vocalizations. Due to the very low levels of baseline

vocalization production, a potential floor effect might
have occurred,

thus making it difficult for any potential

drug-induced decline in vocalizations to occur.

Body Temperature
Considering body temperature, rats were
differentially affected by the administration of different

amounts of fluoxetine

[the main effect of drug condition

was significant, F(3,

88)

= 12.009, p < .05]. Moreover,

F344 rats were affected by the administration of different

amounts of fluoxetine, while SD rats were not.
Specifically,

F344 rats treated with 3 mg/kg of fluoxetine

(M = 35.80°C, SEM - ±0.19) had lower body temperatures

than F344 rats treated with 10 mg/kg (M = 37.03 °C,

SEM = +0.18)

or 3 0 mg/kg of fluoxetine (M = 36.94°C,

SEM = +0.18). The 3mg/kg group also had lower body

temperatures than the vehicle-treated F344. rats.
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Fluoxetine

Figure 4. Mean Ultrasonic Vocalizations (USVs)

for F344

Rats and SD Rats on PD 15. Rats were Treated with Vehicle

or Fluoxetine (1, 10 or 30 mg/kg,

IP)

30 Minutes Prior to

Testing, +Indicates a Significant Difference from SD Rats
(Main Effect of Strain). *Indicates a Significant

Difference from rats treated with 30 mg/kg Fluoxetine
(Main Effect of Drug).

Striatal Monoamine Content and Turnover
Norepinephrine content varied according to rat strain

and sex (strain x sex interaction, F(l, 22)
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= 10.924,

p < .01)

(see Table 5). Specifically, male F344 rats had

higher levels of norepinephrine than male SD rats; while

female 344 rats had lower levels of norepinephrine than
female SD rats.

[Tukey tests, p < .05]. Dopamine and

serotonin content did not differ by rat strain or sex (see
Table 5).
Similar to serotonin,

the content of the serotonin

metabolite 5-HIAA, did not vary by sex or rat strain (see
Table 6) . In contrast, the dopamine metabolite, DOPAC, did

differ by strain and sex. For male rats, F344 rats had

higher levels of DOPAC than SD rats. However,

for female

rats, no significant difference was observed between the
F344 and SD rats,

F(l,22)

[strain x sex interaction,

= 6.607, p < 0.05, and Tukey tests]. Data for the

norepinephrine metabolite, MHPG are unavailable because

MHPG levels fell below the detection range of our HPLC.
Turnover or usage rates for both dopamine and

serotonin varied by rat strain and sex (see Table 7). For

male rats, dopamine turnover was lower for the F344 rats
as compared to the SD rats (F344 = 0.436, SD = 0.536). For

female rats, no significant difference in dopamine
turnover was observed between the F344 and SD rats
(F344 = 0.437, SD = 0.440).

[This is supported by the

51

significant strain x sex interaction,

F(l,

22)

p < .05, and the outcome of the Tukey tests.]

= 5.877,

For male

rats, serotonin turnover was lower for the F344 rats as
compared to the SD rats (F344 = 0.759,
However,

SD = 0.824).

for female rats, serotonin turnover was greater

for F344 rats as compared to the SD rats
SD = 0.747).

(F344 = 0.864;

[This is supported by the significant strain

x sex interaction, F(l, 22)

= 4.835, p < .05, and by the

outcome of the Tukey tests.] Norepinephrine turnover could

not be calculated because MHPG levels were not obtained.
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Table 5. Monoamine Content in F344 and SD Rats on PD 17
Norepinephrine

(ng/mg wet weight tissue)

Female rats

Rat Strain

Male rats

SD

0.205

(± 0.023)

F344

0.280

(± 0.026)** 0.180

0.284

(± 0.040)

x

(M, F)

0.241 (± 0.024)

( + 0.063)
*
**0.227

(± 0.021)

Dopamine (ng/mg wet weight tissue)

Rat Strain

Male rats

SD

4.327

F344

4.270

Female rats

X

(± 0.048)

4.305(± 0.029)

4.317

(± 0.285)

(+ 0.054)

4.427(± 0.056)

4.354

(± 0.043)

(M,

F)

Serotonin (ng/mg wet weight tissue)
Rat Strain

Male rats

Female rats

SD

0.718

(± 0.015)

0.749

(± 0.041)

0.732

(± 0.020)

F344

0.737

(± 0.024)

0.723

(± 0.016)

0.729

(± 0.017)

x {M, F}

F344 and SD male and female rats (n = 6-8 per group) were
injected with vehicle on PD 15 and ultrasonic
vocalizations were assessed for 20 min. On PD 17,
monoamine content was measured.

* Indicates significant difference from female SD rats.
** Indicates significant difference from male SD rats.
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Table 6. Monoamine Metabolite Content in F344 and SD Rats
on PD 17
5- HIAA (ng/mg wet weight tissue)

in the dorsal striatum

Rat Strain

Male rats

SD

0.591

(± 0.043) .

0.569

(+ 0.048)

0.581

(± 0.038)

F344

0.562

(± 0.040)

0.626

(± 0.038)

0.596

(± 0.022)

Female rats

DOPAC (ng/mg wet weight tissue)

X

(M, F}

in the dorsal striatum

Rat Strain

Male rats

Female rats

X

SD

2.320

(± 0.098)

1.894 (± 0.107)

2.126

(± 0.099)

F344

1.867

(± 0.090) *

1.931(± 0.084)

1.902

(± 0.057)

(M, F)

F344 and SD male and female rats (n = 6-8 per group) were
injected with vehicle on PD 15 and ultrasonic
vocalizations were assessed for 20 min. On PD 17,
monoamine metabolite content was measured.
* Indicates significantly different from SD male rats.
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Table 7. Monoamine Turnover Content in F344 and SD Rats on
PD 17
DOPAC'/Dopamine in the dorsal striatum

Rat Strain

Male rats

SD

0.536

F344

0.436

Female rats

x

(± 0.020)

0.440(± 0.018)

0.492

(± 0.022)

(± 0.019)**

0.437(± 0.018)

0.436

(± 0.012)

(M, F)

5-HIAA/Serotonin in the dorsal striatum
Rat Strain

Male rats

Female rats

x

SD

0.824

(± 0.042)

0.747

(± 0.046)

0.789

(+ 0.039)

F344

0.759

(± 0.039)

0.864

(+ 0.037)* 0.815

( + 0.025)

(M, F)

F344 and SD male and female rats (n = 6-8 per group) were
injected with vehicle on PD 15 and ultrasonic
vocalizations assessed for 20 min. On PD 17, monoamine
content and monoamine metabolite content were measure and
monoamine turnover rates were calculated.

* Indicates significant difference from female SD rats.
** Indicates a significance difference from male SD rats.
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CHAPTER EIGHT

DISCUSSION

Introduction

Delays in social communication are a defining feature

of many developmental disorders such as autism
(Constantino & Todd, 2003; Flynn & Healy, 2012).

Unfortunately, few effective treatments exist for
alleviating deficits in social communication and the

development of new therapies has been hampered by a lack

of appropriate animal models

(Klauck & Poustka,

2006).

Recently, F344 rats have emerged as a possible model of
social communication deficits as they naturally display

less play behavior, an important type of developmental
social interaction,

Lewis rats

than other rat strains such as SD and

(Siviy et al., 2011). However, a disadvantage

to this model is that play behavior has a relatively late
onset, while social communication delays appear early in

human children. Thus, the goal of the present thesis was
to determine if F344 rats would also show fewer emissions
of isolation-induced ultrasonic vocalizations

(an early

onset form of social interaction) as compared to SD rats.

We also investigated the role of monoamines in social
communication by using selective monoaminergic compounds
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(i.e., atomoxetine, GBR-12909, and fluoxetine)

to modulate

monoamine activity and by determining monoamine activity

in the striatum.
Ultrasonic Vocalizations
Effects of Rat Strain

We predicted that vehicle-treated F344 rats would

emit fewer isolation-induced ultrasonic vocalizations than
SD rats. However, F344 rats treated with vehicle emitted
more, not fewer, ultrasonic vocalizations. Our findings,
although contrary to our prediction, are supportive of
studies showing that F344 rats differ in social

interaction (i.e.,

social play) when compared to other rat

strains. The higher number of ultrasonic vocalizations
exhibited by F344 rats may also be consistent with a
previous result showing robust behavioral differences in

the F344 rat phenotype,

including hyper-responsiveness to

stress (Kosten & Ambrosio, 2002). Specifically,

the

greater number of ultrasonic vocalizations emitted by F344
rats may be a result of their hyper-responsiveness when
put in stressful situations, such as isolation. Because
both the SD and the F344 rats were tested in the same
environment,

it is unlikely that environmental stimuli •

were responsible for the differences in vocalization

emission rates.
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The difference in the number of vocalizations between
F344 and SD rats could also be related to variations in
body temperature, because body temperature is known to

modulate ultrasonic vocalization production in rat pups.
Specifically,

lowering body temperatures by placing rat

pups in a cool testing environment (10-15 °C)

induces

greater amounts of ultrasonic vocalizations than when rats
are placed in a thermoneutral (35 °C)

testing environment

(Blumberg, Efimova, & Alberts, 1992). Thus, the increased

number of ultrasonic vocalizations emitted by F344 rats
could be a consequence of lower body temperatures as
compared to SD rats. Differences between F344 and SD rats
in body temperature and thermoregulation have been

previously observed in adult male rats, with F344 rats

having a greater loss of body heat in cool environments
(Brown & Pham-Le,

2012). In addition, adult male F344 rats

have elevated body temperature when placed in a warm

chamber (37.1 °C), whereas body temperatures of SD rats
are unaffected by placement in a heated chamber (Brown &
Pham-Le, 2012). These data suggest that F344 rats are less

able to maintain a homeostatic body temperature than SD

rats and this deficit may be partially responsible for
their greater production of ultrasonic vocalizations.
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Effect of Monoamine Modulation

We predicted that GBR-12909 administration would
result in less ultrasonic vocalization production for F344
and SD rats. GBR-12909 is a highly selective dopamine
re-uptake blocker that increases dopamine in the synapse
(Loupe, Bredemeier, Schroder,

& Tessel,

2002). Thus it was

hypothesized that increased dopamine activity would
decrease vocalizations. Additionally, we predicted that

GBR-12909 administration would have a smaller effect on
F344 rats than on SD rats.

The hypothesis regarding the administration of

GBR-12909 was not supported; however, although not
statistically significant, the high dose of GBR-12909

(15 mg/kg) did decrease ultrasonic vocalizations in male
F344 rats. Contrary to our prediction, F344 rats treated

with 1.5 mg/kg GBR-12909 emitted more ultrasonic
vocalization than similarly treated SD rats. The increased
ultrasonic emissions of F344 rats may be a result of lower
levels of synaptic dopamine, because F344 rats release
significantly less dopamine than SD rats when electrically

stimulated or challenged with amphetamine

(Cadoni &

Di Chiara, 2007; Siviy et al., 2011).
In our second experiment, we predicted that

stimulating norepinephrine transmission with atomoxetine
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would result in an increase of ultrasonic vocalization

emissions in F344 and SD rats. Additionally, we predicted
that atomoxetine would have a potentiated effect on F344
rat vocalizations when compared to SD rats. As expected,

F344 rats emitted more ultrasonic vocalizations than SD
rats regardless of atomoxetine dose and atomoxetine
increased ultrasonic vocalizations in both stains in a

dose dependent manner. As compared to F344 rats,
with atomoxetine (1 and 3 mg/kg)

treatment

caused similar (but

smaller) increases in the ultrasonic vocalizations
production of SD rats.
Increased ultrasonic emissions after atomoxetine may

be attributed to the effects of atomoxetine on presynaptic

NET. Atomoxetine has a high affinity for presynaptic NETs,
while leads to significant increases in extracellular

norepinephrine (Bymaster et al., 2 0 02) . In regard to the

current experiment, the greater amount of ultrasonic
vocalizations emitted after atomoxetine is probably the

result of higher level of synaptic norepinephrine.
Adrenergic receptors are known to modulate ultrasonic

vocalizations, because administration of the adrenergic
agonists clonidine or yohimbine increase ultrasonic

vocalizations

(Blumberg et al., 1999; Krall, Andicochea,
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&

McDougall, 2005; Nazarian, Krall, Osburn, & McDougall,
2001).

As predicted, F344 rats, when compared to SD rats

exhibited a potentiated response to atomoxetine. It is
possible that the increased norepinephrine content
observed in F344 rats is indicative of greater adrenergic

system sensitivity. Moreover, the elevated levels of
striatal norepinephrine, may explain why F344 rats have

more basal ultrasonic vocalizations than SD rats.

In our third experiment, we increased serotonin

neurotransmission with fluoxetine. Fluoxetine is a

selective serotonin re-uptake inhibitor (SSRI) used in the
treatment of major depression and other disorders such as

autism (DeLong, Teague,

Fricker, Devi,

& McSwain Kamran,

1998; Taylor,

& Gomes, 2005). We hypothesized fluoxetine

would decrease ultrasonic vocalization emissions in both

rat strains and that the fluoxetine induced enhancement of

serotonin transmission would have a smaller effect on F344

rats than SD rats. In partial support of our hypothesis,
rats treated with the highest dose of fluoxetine

(30 mg/kg) exhibited fewer ultrasonic vocalizations than
rats treated with the lowest dose of fluoxetine (3 mg/kg)

or vehicle-treated rats. We did not find support for the

second part of our hypothesis because there were no
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strain-dependent differences in the effects of fluoxetine

on ultrasonic vocalizations.
The role of serotonin in the regulation of ultrasonic

vocalizations of infant rats is determined by which

serotonin receptor subtypes are stimulated (Olivier,

Molewijk, van der Heyden, van Oorschot, Ronken, Mos,
Miczek,

&

1998). For example, agonists acting on 5HT1A

receptor reduce ultrasonic vocalizations, whereas 5HTiB
receptors agonists and 5HT2A/2c receptor antagonists

stimulate ultrasonic vocalization production (Olivier et
al., 1998). Because fluoxetine (30 mg/kg) decreased
ultrasonic vocalizations it can be inferred that this
reduction in vocalizations was the result of 5HTiA
activation. This hypothesis is supported by a prior

investigation showing fluoxetine-[induced 5HTiA activation

(De Vry, 1996).
.Basal Monoamine Activity
Many previous investigations have demonstrated that

ultrasonic vocalizations are modulated by monoamine
activity (Brunelli & Hofer, 2007; Brunelli & Kehoe, 2005;

Dastur et al.,

1999). Furthermore, F344 rats differ from

other strains in monoaminergic functioning,

differences in dopaminergic,
norepinephrine functions

including

serotonergic, and

(Varty & Geyer, 1998). Thus, we
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hypothesized that differences in basal monoamine activity
could be responsible for differences in the ultrasonic

vocalization emissions of F344 and SD rats. We predicted
that monoamine and monoamine metabolite levels and
monoamine turnover (defined as metabolite/neurotransmitter

level) would differ between F344 and SD rats.
Specifically, we hypothesized that dopamine and serotonin

turnover would be lower in F344 rats, when compared to SD

rats, while norepinephrine turnover would be greater in
F344 rats.
Considering monoamine content, we found that levels
of norepinephrine varied according to rat strain and sex.
Specifically,

consistent with our prediction, male F344

rats had higher levels of norepinephrine than male SD
rats,- however, different from their male counterparts,

female F344 rats had lower levels of norepinephrine than
female SD rats. Dopamine and serotonin did not differ

between the two rat strains.
Considering monoamine metabolite content, we found

that the serotonin metabolite 5-HIAA did not vary by sex
or rat strain. In contrast,

the dopamine metabolite

(DOPAC) differed by strain and sex. Contrary to our

prediction, male F344 rats had higher levels of DOPAC than
male SD rats. This increase of striatal DOPAC levels in
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F344 rats, however, was not observed in female rats.
Levels of MHPG were not analyzed because the levels of
MHPG in most of the samples fell below the detection range

of our HPLC.
Considering monoamine turnover, we found that

serotonin and dopamine turnover did differ by strain, but

the strain effect was moderated by sex. For male rats,
serotonin turnover was lower for the F344 rats as compared
to the SD rats,- however,

for female rats,

serotonin

turnover was greater for F344 rats as compared to the SD
rats. Overall F344 rats had less dopamine turnover than SD

rats, but the difference was only significant in male

rats. Norepinephrine turnover could not be calculated
because MHPG levels were not obtained.

Noradrenergic neurons in the locus coeruleus have

been implicated in the response of the CNS to
environmental stressors (Nisenbaum,

Abercrombie, 1991). Specifically,

Zigmond,

Sved,

&

increases in

norepinephrine levels have been linked to stress-related

events such as isolation (Harvey & Hennessy,
Nisenbaum et al.,

1995;

1991). The results of our study may

indicate that the greater amount of norepinephrine found

in the striatum of male F344 rats may be due to an
enhanced responsiveness to stress during testing.
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The increase in DOPAC levels in male F344 rats is

also consistent with this hypothesis because high levels
of DOPAC are indicative of increased conversion of

dopamine to norepinephrine (Abercrombie & Zigmond,

Nisenbaum et al.,

1989;

1991). Lastly, the increase in serotonin

turnover in female F344 rats seen in this study may be
attributed effects of stress on serotonin turnover

(Papaioannou, Dafni, Alikaridis, Bolaris, &

Stylianopoulou, 2002) . Previously,

the increase of

serotonin turnover was suggested to occur in response to
adaptation of environmental stress during isolation

rearing (Fone & Porkess, 2008). Thus, high levels of
serotonin turnover may suggest that female F344 rats in

this study may also be sensitive to stressful situations.

It should be pointed out that, in our experiments,
the predicted strain effect (i.e., F344 < SD)

for dopamine

and serotonin turnover was moderated by sex.

As reported

earlier, for male rats, dopamine turnover was lower for
the F344 rats as compared to the SD rats, whereas,

for

female rats, no significant difference in dopamine
turnover was observed between the F344 and SD rats. For

male rats,

serotonin turnover was lower for the F344 rats

as compared to the SD rats. However, for female rats,

serotonin turnover was greater for F344 rats as compared
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to the SD rats. The reason why male but not female F344

rats showed the expected differences in monoamine systems

is still an open question. However, if the observed sex

difference can be validated, it could be important for
understanding the differential prevalence of social
communication disorders like autism in male and female

children (Fombonne, 2005; Matson & Kozlowski, 2011).

Conclusions

Overall our study revealed that atypical social
communication can be detected in F344 rats at a young age.

When compared to SD rats, F344 rats had increased
ultrasonic vocalizations emission. This finding of
ultrasonic vocalization production did not support our
hypotheses, but our data do support the existing

literature indicating that F344 rats when compared to
other strains of albino rats display different patterns of

social communication. Thus, I believe that
isolation-induced ultrasonic vocalizations in F344 rats
could be a useful model for social communication

disorders, if the potential confounding effect associated

with differences in body temperature regulation evident in

F344 rats compared to SD rats can be properly controlled.
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Although our results revealed, differences in
monoaminergic systems between F344 and SD rats, the
activation of dopaminergic and serotoninergic systems

produced similar effects on ultrasonic vocalization

production in both strains. In contrast the activation of

adrenergic systems by atomoxetine produced greater
ultrasonic vocalization production in F344 rats than SD
rats. This strain dependent difference in ultrasonic

vocalization production suggests that enhanced
norepinephrine activity may be important for understanding

the differences in social communication between F344 and

SD rats. However, it is likely that other neurochemical
messengers such as hormones

(i.e., oxytocin and

vasopressin), and opioids may play an important role in

the modulation of social deficits. Vasopressin and
oxytocin are known to be important in the regulation of

social bonding (Klopfer, 1971) and both hormones reduce
the frequency of isolation-induced ultrasonic

(Insel & Winslow, 1991;

vocalizations in infant rats

Winslow & Insel,

1993). Endogenous opioids have also been

associated with social behaviors in human children

(Panskepp, Nelson, & Bekkdal,

1997) and in the deficits of

social behavior seen in psychiatric disorders such as
autism (Panskepp, 1979). In summary, we believe our

67

findings provide a possible direction for future research

on the use of ultrasonic vocalizations in F344 rats as a
model of social communication deficits. Moreover, we

believe studies assessing the modulation of ultrasonic

vocalizations by vasopressin, oxytocin, and the endogenous

opioid activity are warranted.

68

REFERENCES

Abercrombie, E. D., & Zigmond, M. J.

(1989). Partial

injury to central noradrenergic neurons: Reduction of
tissue norepinephrine content is greater than

reduction of extracellular norepinephrine measured by
microdialysis. Journal of Neuroscience,
Aitken, A. R.,

& Tork, I. N.

9, 4062-4067.

(1988). Early development of

serotonin-containing neurons and pathways as seen in
whole mount preparations of the fetal rat brain.

Journal of Comparative Neurology, 274, 32-47.

Allin, J., & Banks, E. M.

(1970). Effects of temperature

on ultrasound production by infant albino rats.

Developmental Psychobiology,
American Psychiatric Association.

4,

149-156.

(2000). Diagnostic

criteria for autistic disorder. Diagnostic and

statistical manual of mental disorders (4th, text
revision). Washington, DC: American Psychiatric
Association,

(pp. 70-75).

Antonopoulos, J., Dori, I., Dinopoulos, A.,

& Parnavelas, J. G.

Chiotelli, M.,

(2002). Postnatal development of

the dopaminergic system of the striatum in the rat.
Neuroscience,

2, 245-256.

69

Auger, A. P.,

& Olesen, K. M.

(2009). Brain sex

differences and the organisation of juvenile social

play behavior. Journal of Neuroendocrinology, 21,

519-525.
Baenninger, L. P.

(1967) . Comparison of behavioural

development in socially isolated and grouped rats.
Animal Behaviour,
Bauman, M. L.,

15, 312-323.

& Kemper, T. L.

(1994). Neuroanatomic

observations of the brain in autism. Neurobiology of
Autism,

23,

119-145.

Beatty, W. W., Costello, K. B.,

& Berry, S. L.

(1984).

Suppression of play fighting by amphetamine: effects
of catecholamine antagonists, agonists and synthesis
inhibitors. Pharmacology, Biochemistry and Behavior,

20, 747-755.
i

Bekoff, M.

(1972) . The development of social interaction,

play and metacommunication in mammals, an ethological
perspective. Quarterly Review of Biology,

47,

412-434.
Bekoff, M.

(1974). Social play and play-soliciting by

infant canids. American Zoology,

70

14,

323-340.

Best, J., Nijhout, H. F., & Reed, M.

synthesis,

(2010). Serotonin

release and reuptake in terminals: A

mathematical model. Theoretical Biology and Medical

Modelling,

7, 2-26.

Binder, E. B., Kinkead, B., Owens, M. J.,

B.

& Nemeroff, C.

(2001). Neurotensin and dopamine interactions.

Pharmacological Reviews,
Blumberg, M. S., Efimova,

53, 453-486.

I. V.,

& Alberts, J. R.

(1992).

Ultrasonic vocalizations by rat pups: The primary

importance of ambient temperature and the thermal

significance of contact comfort. Developmental

Psychobiology, 25, 229-250.

Blumberg, M. S., Sokoloff, G., & Kent, K. J.

(1999).

Cardiovascular concomitants of ultrasound production

during cold exposure in infant rats. Behavioral

Neuroscience,

113,

1274-1282.

Bodfish, J. W., Symons, F. J., Parker, D. E., & Lewis, M.
H.

(2000) . Varieties of repetitive behavior in

autism: Comparisons to mental retardation. Journal of
Autism and Developmental Disorders, 30,
Bolles, R. C.,

& Woods, P. J.

237-243.

(1964). The ontogeny of

behavior in the albino rat. Animal Behaviour,
427-441.

71

12,

Bortolato, M. , Chen, K., & Shih, J. C.

(2008). Monoamine

oxidase inactivation: From pathophysiology to

therapeutics. Advanced. Drug Delivery Reviews,

60,

1527-1533.

Broaddus, W. C., & Bennett, Jr. J. P.

(1990). Postnatal

development of striatal dopamine function. I. An

examination of DI and D2 receptors,

adenylate cyclase

regulation and presynaptic dopamine markers.

Developmental Brain Research,

Brown, J. W.,

& Pham-Le, N. M.

52,

265-271.

(2012). The effect of

thermopreference on circadian thermoregulation in
Sprague-Dawley and Fisher 344 rats. Journal of
Thermal Biology. 37, 309-315.

Brown, W. H., Odom, S. L., & Holcombe, A.

(1996).

Observational assessment of young children's social

behavior with peers. Early Childhood Research
Quarterly,

11, 19-40.

Brunelli, S. A., & Hofer, M. A.

(2007). Selective breeding

for infant rat separation-induced ultrasonic
vocalizations: Developmental precursors of passive
and active coping styles. Behavioural Brain Research,

182,

193-207.

72

Brunelli, S. A., & Kehoe, P.

(2005). Differences in

catecholamine utilization at postnatal day 10 in rats

selected for ultrasonic vocalization (USV) responses
to maternal separation. Developmental Psychobiology,
47, 421.

Buitelaar, J. K., Swinkels, S. H. N., De Vries, H., van
der Gaag, R. J., & Van Hooff, J. A. R. A. M.

(1994).

An ethological study on behavioural differences

between hyperactive, aggressive, combined
hyperactive/aggressive and control children. Journal
of Child Psychology and Psychiatry, 35,

1437-1446.

Buitelaar, J. K., Van Engeland, H., de Kogel, K. H., De

Vries, H.,

& Van Hooff, J. A. R. A. M.

(1991).

Differences in the structure of social behavior of
autistic children and non-autistic retarded controls.

Journal of Child Psychology and Psychiatry, 32,
995-1015.

Bymaster, F. P., Katner, J. S., Nelson, D. I.,
Hemrick-Luecke, S. K., Threlkeld,

Heiligenstein, J. H.

P. G.,

&

(2002). Atomoxetine increases

extracellular levels of norepinephrine and dopamine

in prefrontal cortex of rat: A potential mechanism
for efficacy in attention deficit/hyperactivity

disorder. Neuropsychopharmacology,

73

27,

699-711.

Cadoni,

C. & Di Chiara, G.

(2 007) . Differences in dopamine

responsiveness to drugs of abuse in the nucleus

accumbens shell and core of Lewis and Fischer 344
rats. Journal of Neurochemistry,
Caine, D., Chase, T. N. ,

& Barbeau, A.

103,

487-499.

(1975).

Dopaminergic mechanisms. Advances in Neurology.

Vol.

9. New York: Raven Press.

Carlsen, J., & Heimer, L.

(1986). The projection from the

peritoneal thalamic nucleus, as demonstrated by the

phaseolus vulgaris-leucoagglutinin (PHA-L) method,

identifies a sub territorial organization of the

ventral striatum. Brain Research,
Carlson, N. R.

374, 375-379.

(2001) . Physiology of Behavior (7th ed.) .

Boston, MA: Allyn and Bacon,

(pp. 96-129).

Civelli, O., Bunzow, J. R., & Grandy, D. K.

(1993).

Molecular diversity of the dopamine receptors. Annual
Review of Pharmacology and Toxicology, 33,
Constantino, J. N., & Todd, R. D.

281-307.

(2003). Autistic traits

in the general population: A twin study. Archives of
General Psychiatry, 5,

524-530.

Corbett, B. A., Schupp, C. W., Levine,

(2009). Comparing cortisol,

S.,

stress,

& Mendoza, S.

and sensory

sensitivity in children with autism. Autism Research,

2, 39-49.

74

Courchesne, E.

(2004). Brain development in autism: Early

overgrowth followed by premature arrest of growth.

Mental Retardation and Developmental Disabilities
Research Reviews, 10,

106-111.

Courchesne, E., & Pierce, K.

(2005). Brain overgrowth in

autism during a critical time in development:
Implications for frontal pyramidal neuron and
interneuron development and connectivity.

International Journal of Developmental Neuroscience,

23,

153-170.

Courchesne, E., Redcay, E.,

& Kennedy, P.

(2004). The

autistic brain: Birth through adulthood.

Current

Opinion in Neurology, 17, 489-496.

Cuomo, V., Cagiano, R., Renna, G., DeSalvia, M. A.,

Racagni, G.

&

(1987). Ultrasonic vocalization in rat

pups: Effects of early postnatal exposure to SCH
23390

(a DAi-receptor antagonist)

and sulpiride

DA2-antagonist) . Neuropharmacology,

Dastur, F. N., McGregor, I. S.,

32,

(a

701-705.

& Brown, R. E.

(1999).

Dopaminergic modulation of rat pup ultrasonic

vocalizations. European Journal of Pharmacology,
53-67.

75

382,

Dawson, G., Munson, J., Estes, A., Osterling, J.,
McPartland, J., Toth, K., Carver, L.,

& Abbott, R.

(2002). Neurocognitive function and joint attention
ability in young children with autism spectrum

disorder versus developmental delay.
Development,

Child

73, 345-358.

Dayan, P., & Huys, Q. J. M.

(2008) . Serotonin,

inhibition,

and negative mood. PLoS Computational Biology,

4,

1-11.
Delmonte, S., Balsters, J. H., McGrath, J., Fitzgerald,
J., Brennan, S., Fagan, A. J.,

& Gallagher, L.

(2012). Social and Monetary reward processing in
autism spectrum disorders. Molecular Autism,
DeLong, G. R., Teague, L. A.,

& McSwain, M.

3, 1-13.

(1998).

Effects of fluoxetine treatment in young children
with idiopathic autism. Developmental Medicine and

Child Neurology, 40, 551-562.
Dent, G. W., Smith, M. A.,

& Levine, S.

(2001).

Stress-induced alterations in locus coeruleus gene

expression during ontogeny. Developmental Brain
Research,
Devoto,

127, 23-30.

P., & Flore, G.

(2006). On the origin of cortical

dopamine: Is it a co-transmitter in noradrenergic
neurons. Current Neuropharmacology,

76

4, 115-125.

De Vry,

J.

The role of 5-HTiA receptors in

(1996).

psychopathology and in the mechanism of action of

clinically effective therapeutics.

Drug News and

9, 270-280.

Perspectives,

Di Martino, A., Kelly, C., Grzadzinski, R., Zuo, X.,
f
Mennes, M., Mairena, M. A., Lord, C., Castellanos,

X.,

& Milham,

M.

F.

(2011). Aberrant Striatal

P.

Functional Connectivity in Children with Autism.

Biological Psychiatry,
K.

Dominick,

Davis,

C.,

S.

Folstein,

0.,

N.

(2007).

69,

847-856.

Tager-Flusberg,

H.,

&

Atypical behaviors in children

with autism and children with a history of language

Research in Developmental Disabilities,

impairment.

28,

145-162.

Elsworth,

J.,

uptake,

& Roth,

R.

metabolism,

H.

(1997). Dopamine synthesis,

and receptors:

therapy of Parkinson's disease.

Neurology,
Flynn,

L.,

Relevance to gene

Experimental

144, 4-9.

& Healy,

0.

(2012).

A review of treatments for

deficits in social skills and self-help skills in

autism spectrum disorder.

Disorders,

6, 431-441.

77

Research in Autism Spectrum

E.

Fombonne,

The changing epidemiology of autism.

(2005).

Journal of Applied. Research in Intellectual
Disabilities,
K.

Fone,

F.,

C.

Id, 281-294.

& Porkess,

V.

M.

(2008).

Behavioural and

neurochemical effects of post-weaning social

isolation in rodents-relevance to developmental

Neuroscience and

neuropsychiatric disorders.

Biobehavioral Reviews,
Ford,

P.,

C.

J.

T.

Gantz,

(2010).

S.

C.,

32,

1087-1102.

Giedd,

E.

M.,

& Williams,

Control of extracellular dopamine at

dendrite and axon terminals.

30,

P.

Phillips,

Journal of Neuroscience,

6975-6983.
Keshavan,

J. N.,

M.,

& Paus,

(2009).

T.

Why do many

psychiatric disorders emerge during adolescence.

Nature Reviews Neuroscience, 12,
Gillberg,

C.,

& Svennerholm,

L.

947-957.

(1987).

CSF monoamines in

autistic syndrome and other pervasive developmental

disorders of early childhood.

Psychiatry,
Gillis,

J. M.,

151,

British Journal of

89-94.

Callahan,

E.

H.,

& Romanczyk,

R.

G.

(2011).

Assessment of social behavior in children with
autism:

The development of the behavioral assessment

of social interactions in young children.

Autism Spectrum Disorders,

78

5, 351-360.

Research in

J.

Gingrich,

A.,

& Caron,

M.

G.

(1993).

Recent advances in

the molecular biology of dopamine receptors.

Review of Neuroscience, 16,
Harvey, A.

& Hennessy,

T.,

M.

Annual

299-321.

Corticotropin

(1995).

B.

releasing factor modulation of ultrasonic

vocalization rate of isolated rat pups.

Brain Research,
Hodgson,

R. A.,

Developmental

87, 125-134.

Guthrie,

D.

H.,

& Varty,

G.

B.

(2008) .

Duration of ultrasonic vocalizations in the isolated
rat pup as a behavioral measure:

Sensitivity to

anxiolytic and antidepressant drugs.

Biochemistry and Behavior,
Hofer,

M. A.

(1996).

88,

Pharmacology,

341-348.

Multiple regulators of ultrasonic

vocalization in the infant rat.

Psychoneuroendocrinology, 21,
Hofer,

M. A. ,

&. Shair,

H.

(1978).

203-217.
Ultrasonic vocalization

during social interaction and isolation in 2-week old
rats.

Hoyer,

D.,

Developmental Psychobiology,
Clarke,

Mylecharane,
A.

(1994).

D.
E.

E.,

J.,

Fozard J.
Saxena,

P.

11, 495-504.

R., Hartig, G. R.,
R. ,

& Humphrey,

P.

P.

International union of pharmacology

classification of receptors for 5-hydroxytryptamine

(serotonin).

Pharmacology, 46,

79

157-203.

Hoyer,

D.,

Hannon,

Molecular,

J.

P.,

P.

(2002).

Pharmacology, Biochemistry and

71, 533-554.

Behavior,
Z.,

G.

pharmacological and functional diversity

of 5-HT receptors.

Hu,

& Martin,

Cooper,

M.,

Crockett,

D.

P.,

& Zhou,

R.

(2004).

Differentiation of the midbrain dopaminergic pathways

during mouse development.

Neurology,
Insel,

T.

R.,

Journal of Comparative

476, 301-311.

& Winslow,

J.

T.

(1991).

Central

administration of oxytocin modulates the infant rat's

response to social isolation.

Pharmacology,
Jackson,

D.

M.,

receptors:

European Journal of

203, 149-152.

& Westlind-Danielsson,

Molecular biology,

behavioural aspects.

A.

(1994).

Dopamine

biochemistry and

Pharmacology and Therapeutics,

64, 291-370 .
JanuSonis,

S.

(2008).

of autism.

5,
Johnson,

Origin of the blood hyperserotonemia

Theoretical Biology and Medical Modeling,

1-16.
C.

P.,

Myers,

S.

M.,

& American Academy of

Pediatrics Council on Children with Disabilities.

(2007).

Identification and evaluation of children

with autism spectrum disorders.
1183-1215.

80

Pediatrics,

120,

Kalsbeek, A., Voorn, P., Buijs, R. M., Pool,

Uylings, H. B. M.

C. W. ,

&

(1988). Development of the

dopaminergic innervations in the prefrontal cortex of

the rat. Journal of Comparative Neurology,

1, 58-72.

Kehne, J. H., McCloskey, T. C., Baron, B. M., Chi, E.,
Harrison, B. L., Whitten, J. P.,

& Palfreyman, M. G.

(1991). NMDA receptor complex antagonist have
potential anxiolytic effects as measured with
separation-induced ultrasonic vocalizations. European
Journal of Pharmacology,

Kehoe, P.

193, 283-292.

(1988). Ontogeny of adrenergic and opioid

effects on separation vocalizations in rats.

In:

(Ed.). The physiological control of

Newman J.D.

mammalian vocalization. Plenum, New York,

(pp.

301-320) .

Kirkpatrick, B.

(1994). Psychiatric disease and the

neurobiology of social behavior. Biological
Psychiatry,
Kirsten,

36, 501-502.

T. B., Chaves-Kirsten,

Silva, A. C.

Dagli, M. L

G. P., Chaible, L. M.,

Martins, D. O.

Britto,

Z., Torra~o, A. S.,

Bernardi, M. M.

L. R. G.,

Palermo-Neto, J.,

(2012). Hypoactivity of the Central

Dopaminergic System and Autistic-Like Behavior

Induced by a Single Early Prenatal. Exposure to

81

&

Lipopolysaccharide. Journal of Neuroscience Research,
90,

1903-1912.

Klauck, S. M., & Poustka, A.

(2006). Animal models of

autism. Drug Discovery Today: Disease Models,

3,

313-318.

Klopfer, P. H.

(1971). What turns it on? Ammons

Scientific,

59, 404-407.

Knutson, B., Burgdorf, J.,

& Panksepp, J.

(1998).

Anticipation of play elicits high-frequency
ultrasonic vocalizations in young rats. Journal of
Comparative Psychology, 112,

Kosten, T. A., & Ambrosio, E.

65-73.

(2002). HPA axis function

and drug addictive behaviors: Insights from studies

with Lewis and Fischer inbreds rats.
Psychoneuroendocrinology, 27, 35-69.

Krall, C. M., Andicochea, C. T.,

& McDougall, S. A.

(2005) . Ultrasonic vocalization production of
preweanling rats: Effects of central and peripheral

administration of a-adrenoceptor agonists. European
Journal of Pharmacology, 517,
Lam, K. S. L., & Aman, M. G.

behavior scale-revised:

200-207.

(2007). The repetitive

Independent validation in

individuals with autism spectrum disorders. Journal

of Autism and Developmental Disorders,

82

37,

855-866.

Lam, K. S. L., Aman, M. G.,

& Arnold, L. E.

(2006).

Neurochemical correlates of autistic disorder: A

review of the literature. Research in Developmental
Disabilities,

Landa, R.

27, 254-289.

(2007) . Early communication development and

intervention for children with autism. Mental

Retardation and Developmental Disabilities Research

Reviews, 13, 16-25.
Landa, R. , Holman, K. C.,

& Garrett-Mayer, E.

(2007).

Social and communication development in toddlers with

early and latter diagnosis of autism spectrum
disorders. Archives of General Psychiatry,

64,

853-864.
Levy, S. E., Mandell, D. S., & Schultz, R. T.

Autism. Lancet, 374,

(2009).

1627-1638.

Liu, K., King, M., & Bearman P. S.

(2010). Social

influences and the autism epidemic. American Journal

of Sociology,

115,

1387-1434.

Lore, R. K., & Planelly, K.

(1977). Rat societies.

Scientific American, 236,

83

106-116.

Loupe,

P.

R.

Tessel,

J.

Bredemeier,

S.,

E.

D. ,

Schroeder,

S.

R.,

&

(2002). Dopamine re-uptake inhibitor

GBR-12909 induction of aberrant behaviors in animal

International Journal

models of dopamine dysfunction.

of Developmental Neuroscience, 20,
K. ,

Maciag,

Emili,

J.,

L.

F.

S.

Altschuler,

A.,

(2006).

J.,

M.

Slack,

F. ,

J.

Greenblatt,

323-333.
D.,

Krogan,

Maniatis,

T.,

N.

& Wu,

Systems-level analyses identify

extensive coupling among gene expression machines.

Molecular Systems Biology,
Matson,

J.

L.,

A.

& Kozlowski,

2, 1-14.
M.

(2011).

The increasing

prevalence of autism spectrum disorders.

Research in

Autism Spectrum Disorders, 5, 418-425.
Meany,

M.

J.,

& Stewart,

J.

(1981).

Neonatal androgens

influence the social play of pubescent rats.

and Behavior,
Meany,

M.

J.,

15, 197-213.

Stewart,

J.,

& Beatty,

differences in social play,

W.

W.

(1985).

(2009).

K.

R.,

Nakamura,

E.

Sex

the socialization of sex

roles. Advances in the Study of Behavior,
Merikangas,

Hormones

F.,

& Kessler,

15,
R.

1-58.

C.

Epidemiology of mental disorders in children

and adolescents.

Dialogues,

84

11,

7-20.

A.,

C.

Missale,

M.

Caron,

Nash,

R. ,

S.

Robinson,

W.,

S.

(1998). Dopamine receptors:

G.

structure to function.

Jaber,

&

M.,

From

Physiology Reviews,

78,

189-225 .
Murrin,

L.

Sanders,

C.,

D.,

J.

& Bylund,

D.

B.

(2007).

Comparison of the maturation of the adrenergic and

serotonergic neurotransmitter systems in the brain:
Implications for differential drug effects on

Biochemical Pharmacology,

juveniles and adults.

73,

1225-1236.

M. ,

Narayan,

(1992).

Srinath,

S.,

Anderson,

G.

M.,

& Meundi,

D.B.

Cerebrospinal fluid levels of homovanillic

acid and 5-hydroxyindoleacetic acid in autism.

Biological Psychiatry, 33,
National Research Council.

630-635.

(2010).

Guide for the care and

use of laboratory animals. National Academy Press,
Washington,
Nazarian,

A.

A.,

Krall,

(2001).

rats:

DC.
C.

M. ,

Osburn,

J.

R.,

& McDougall,

Ultrasonic vocalizations of preweanling

involvement of both a2-adrenoreceptor and k-

opioid receptor systems.

Pharmacology,

European Journal of

415, 165-171.

85

S.

Neckameyer,
S.

F.

S.,

W.

(2007).

Coleman,

M.,

C.

Eadie,

S.,

& Goodwin,

Compartmentalization of neuronal and

peripheral serotonin synthesis in Drosophila

Melanogaster. Genes, Brain and Behavior,
Nelson,

E.

E.,

& Panskepp,

J.

756-769.

Brain substrates of

(1998).

Contributions of opioids,

infant-mother attachment:

oxytocin,

6,

Neuroscience and

and norepinephrine.

Biobehavioral Reviews, 22, 437-452.
Nisenbaum,

L.

K.,

Abercrombie,

Zigmond,

E. D.

M.

J.,

Sved,

A.

F.,

&

Prior exposure to chronic

(1991).

stress results in enhanced synthesis and release of

hippocampal norepinephrine in response to a novel

Journal of Neuroscience,

stressor.
Noens,

I.,

Duijn,

van Berckelaer-Onnes,

(2006).

G.

I.,

11,

1478-1484.

Verpoorten,

R.,

& van

The ComFor: An instrument for the

indication of augmentative communication in people
with autism and intellectual disability.

Intellectual Disability Research,
Normansell,

L.,

& Panksepp,

J.

(1985).

50,

Journal of

621-632.

Effects of

quipazine and methysergide on play in juvenile rats.

Pharmacology, Biochemistry and Behavior, 22,
O'Dowd,

B.

F.

(1993).

885-887.

Structures of dopamine receptors.

Journal of Neurochemistry,

86

60,

804-816.

B.,

Olivier,

Van Oorschot,
A.

(1998) .

R.,

van der Heyden,

E.,

H.

Molewijk,

Ronken,

E.,

Mos,

Biobehavioral Reviews,
M.

E.,

(2008) .

M.,

& Miczek,

J.,

K.

Ultrasonic vocalizations in rat pups:

effects of serotonergic ligands.

Page,

J. A.

Oropeza,

23, 215-227.

C.,

V.

Neuroscience and

& Van Bockstaele,

E.

J.

Local administration of a cannabinoid agonist

alters norepinephrine efflux in the rat frontal
cortex.

Panskepp,

J.

Neuroscience Letters,

(1979). A neurochemical theory of autism.

Trends in Neuroscience, 2,
Panksepp,

J.,

431, 1-5.

& Beatty,

W.

W.

174-177.

(1980).

Social deprivation

Behavioral and Neural Biology,

and play in rats.

30,

197-206.

Panskepp,

J.,

Nelson,

E.,

& Bekkedal,

M.

(1997).

Brain

systems for the mediation of social separation

distress and social-reward.

Academy of Sciences,
Papaioannou,

A.,

Dafni,

& Stylianopoulou,

807,

U.,
F.

Annals of the New York

78-100.

A. Alikaridis,

(2002) .

F.,

Bolaris,

S.

Effects of neonatal

handling on basal and stress-induced monoamine levels
in the male and female rat brain.

195-206.

87

Neuroscience, 114,

Pardo,

& Eberhart,

A.,

C.

Brain Pathology,

of autism.

Pares-Herbute,

N.,

The neurobiology

(2007).

G.

C.

17,

434-447.

L.,

Tapia-Arancibia,

& Astier,

Ontogeny of the metencephalic,

(1989) .

H.

mesencephalic

and diencephalic content of catecholamines as
measured by high performance liquid chromatography

International Journal

with electrochemical detection.

of Developmental Neuroscience,
Poole,

B.,

T.

Sc Fish, J.

7,

73-79.

(1975). An investigation of

playful behavior of Rattus norvegicus and mus

muscuius (Mammalia). Journal of Zoology (London),
175,
Rao,

61-71.

A.,

P.

Molinoff,

P.

& Joyce,

B.,

J.

N.

(1991).

Ontogeny of dopamine DI and D2 receptor subtypes in
rat basal ganglia:. A quantitative autoradiographic

Developmental Brain Research,

study.

Rapin,

I.,

Sc Tuchman R. F.

neurobiology,

screening,

of North America,
Ressler,

K.,

(2008).

55,

& Nemeroff,

C.

60,

Autism:

diagnosis.

161-177.

Definition,

Pediatric Clinics

1129-1146.

B.

(1999).

Role of

norepinephrine in the pathophysiology and treatment

of mood disorders.

Biological Psychiatry,

1219-1233.

88

46,

Roberts,

J.,

P.

G. N.,

Woodruff,

& Iversen,

L.

L.

(1978).

Dopamine. Advances in biochemical psychopharmacology.

Vol. 19. New York: Raven Press.
Rogers,

J.

S.

(2009).

What are infant siblings teaching us

about autism in infancy? Autism Research,
J.

Rubenstein,

L.

Sales,

Biological Psychiatry,

145-150.

Martres,

N.,

J.

125-137.

Development of serotonergic

(1998).

neurons and their projections.

44,

2,

(1989).

C.

M.

P.,

Bouthenet,

L.,

M.

& Schwartz,

Ontogeny of dopaminergic D-2 receptors
Characterization and

in the rat nervous system:

detailed autoradiographic mapping with 112511 iodo

Neuroscience,

sulpride.

M.

Scanttoni,

L.,

28,

J.,

Crawley,

Ultrasonic vocalizations:

673-700.

& Ricceri,

L.

(2009).

A tool for behavioural

phenotyping of mouse models of neurodevelopmental
disorders.

33,

508-515.

Schambra,

M.

Neuroscience and Biobehavioral Reviews,

B.,

U.

G.,

Duncan,

Caron,

M.

G.,

G.

E.,

Breese,

& Fremeau,

Jr.

G.

R.

R.,

T.

Fornaretto,
(1994).

Ontogeny of DiA and D2 dopamine receptor subtypes in
rat brain using in situ hybridization and receptor

binding.

Neuroscience,

62,

89

65-85.

Sealfron,

S. C.,

& Olanow, C. W.

(2000). Dopamine

receptors: From structure to behavior.
Neurosciences ,

Trends in

23, S34-S40.

Shair, H. N., Masmela, J. R., & Hofer, M.

(1999). The

influence of olfaction on potentiation and inhibition

of ultrasonic vocalization of rat pups. Physiology
and Behavior,

65, 769-772.

Sigman, M., Dijamco, A., Gratier, M., & Rozga, A.

(2004).

Early detection of core deficits in autism. Mental
Retardation and Developmental Disabilities Research

Reviews,

10, 221-233.

Siviy, S. M., Crawford, C. A., Akopian, G.,

& Walsh, J. P.

(2011). Dysfunctional play and dopamine physiology in
the Fischer rat. Behavioural Brain Research,

220,

294-304.

Siviy, S. M., Fleischhauer, A. E., Kuhlman, S. L.,

Atrens,

D. M.

&

(1994) . Effects of ot2-adrenoreceptor

antagonists on rough-and-tumble play in juvenile

rats: Evidence for a site of action independent of
non-adrenoceptor imidazoline binding sites.
Psychopharmacology,

113, 493-499.

90

Siviy, S. M.t Love, N. J. , DeCicco, B. M., Giordano, S.
B., & Seifert, T. L.

(2003). The relative playfulness

of juvenile Lewis and Fischer-344 rats. Physiology
and Behavior,

Siviy, S. M.,

80, 385-394.
(2011). In search of the

& Panksepp, J.

neurobiological substrates for social playfulness in
mammalian brains. Neuroscience and Biobehavioral

Reviews, 35, 1821-1830.
Skolnick, P., & Daly, J. W.

(1977). Strain differences in

responsiveness of norepinephrine-sensitive adenosine
3',

5'-Monophosphate-generating systems in rat brain

slices after intraventricular administration of

6-hydroxydopamine. European Journal of Pharmacology,
41,

145-152.

Sofuoglu, M. ,

Sc Sewell, R. A.

(2008) . Norepinephrine and

stimulant addiction. Addiction Biology,

14,

119-129.

Specht, L. A., Pickel, V. M., John, T. H., & Reis, D. J.

(1981). Light-microscopic immunocytochemical
localization of tyrosine hydroxylase in prenatal rat

brain. I. Early ontogeny. Journal of Comparative
Neurology,

199,

233-253.

91

Tager-Flusberg,

& Caronna,

H.,

E.

Language

(2007).

disorders:

Autism and other pervasive developmental

disorders.

Pediatric Clinics of North America,

54,

469-481.

Taylor,

A.

Fricker,

C.,

D.,

Devi,

A.,

L.

& Gomes,

I.

(2005). Mechanisms of action of antidepressants:
neurotransmitter systems to signaling pathways.

Signal,
Tully,

K.,

& Bolshakov,

V.

synaptic plasticity.

L.,

Cell

17, 549-557.
Y.

enhancement of memory:

Uphouse,

From

S.,

Maswood,

Prullage,

How norepinephrine enables

Molecular Brain,
A.,

Jackson,

Brown-Myers,

J.,

Emotional

(2010).

T.,

3, 1-9.

Brown,

K.,

& Shaheen,

F.

(2002).

Strain differences in the response to the 5-HTla

receptor agonist,

8-OH-DPAT.

Biochemistry and Behavior,
Vanderschuren,
J.

M.

L.

J.

M.

J.,

Pharmacology,

72,

Niesink,

533-542.
R.

J.

M.,

& Van Ree,

The neurobiology of social play

(1997).

behavior in rats.

Neuroscience and Biobehavioral

Reviews, 21, 309-326.
Vanderschuren,
M.,

L.

J.

& Van Ree,

M.

J.

J.,

M.

Niesink,

(1995).

R.

J.

M.,

Spruijt,

Influence of

environmental factors on social play behavior of
juvenile rats.

Physiology & Behavior,

92

58,

119-123.

B.

Varty,

G.

B.,

& Geyer,

M.

(1998).

A.

on startle reactivity,

habituation,

inhibition in male Lewis,

K. ,

Chawarska,

F.,

and prepulse
and Fischer

Sprague-Dawley,

112, 1450-1457.

Behavioral Neuroscience,

344 rats.
Volkmar,

Effects of isolation

& Klin A.

(2005).

Autism in

infancy and early childhood. Annual Review of

Psychology, 56, 315-336.
Wanat,

M.

M.

J.,

Willuhn,

(2009) .

I.,

Clark,

Weiner,

G.,

J.,

& Phillips,

P.

Current Drug Abuse Reviews,

195-213.
N. ,

& Molinoff,

Agranoff,

B.,

P.

(1994).

Albers,

R.,

Catecholamines.

Molinoff,

P.

Siegel,

Basic

neurochemistry: Molecular, cellular, and medical
aspects. 5th edition. New York: Raven Press Ltd,
261-281.
Winslow,

E.

Phasic dopamine release in appetitive

behaviors and drug abuse.

2,

J.

J.

T.,

& Insel,

T.

R.

(1990).

Serotonergic

modulation of rat pup ultrasonic vocal development:
studies with 3,4-methylenedioxymethamphetamine.

Journal of Pharmacology and Experimental

Therapeutics, 254, 212-220.

93

Winslow,

J.

T. ,

& Insel,

T.

R.

Infant rat

(1991).

separation is a sensitive test for novel anxiolytics.

Progress in Neuropsychopharmacology and Biological

15, 745-757.

Psychiatry,
J.

Winslow,

T.,

& Insel,

T.

R.

Effects of central

(1993).

vasopressin administration to infant rats.

Journal of Pharmacology,
Young,

K.

A.,

Liu,

Y.,

& Wang,

European

233, 101-107.
Z.

(2008).

The neurobiology

of social attachment: A comparative approach to
behavioral,
studies.

neuroanatomical,

and neurochemical

Comparative Biochemistry and Physiology Part

C: Toxicology and Pharmacology,
Yu,

P. ,

He,

Wang,

F.,

J.,
An,

Tai,
X.,

F.,

& Wu,

Broders,

R.

148,
H.,

(2011).

401-410.

An,

S.,

Zhang,

X. ,

The effects of

repeated early deprivation on ultrasonic

vocalizations and ontogenetic development in mandarin
vole pups.

Behavioural Processes,

94

88,

162-167.

